Recognition of valine transfer RNA by valyl-tRNA synthetase from E coli: 19F NMR and aminoacylation studies involving wild type and mutant forms of 5-fluorouracil-substituted tRNAVal by Chu, Wen-Chy
Retrospective Theses and Dissertations Iowa State University Capstones, Theses andDissertations
1989
Recognition of valine transfer RNA by valyl-tRNA
synthetase from E coli: 19F NMR and
aminoacylation studies involving wild type and
mutant forms of 5-fluorouracil-substituted
tRNAVal
Wen-Chy Chu
Iowa State University
Follow this and additional works at: https://lib.dr.iastate.edu/rtd
Part of the Biochemistry Commons
This Dissertation is brought to you for free and open access by the Iowa State University Capstones, Theses and Dissertations at Iowa State University
Digital Repository. It has been accepted for inclusion in Retrospective Theses and Dissertations by an authorized administrator of Iowa State University
Digital Repository. For more information, please contact digirep@iastate.edu.
Recommended Citation
Chu, Wen-Chy, "Recognition of valine transfer RNA by valyl-tRNA synthetase from E coli: 19F NMR and aminoacylation studies
involving wild type and mutant forms of 5-fluorouracil-substituted tRNAVal" (1989). Retrospective Theses and Dissertations. 8920.
https://lib.dr.iastate.edu/rtd/8920
INFORMATION TO USERS 
The most advanced technology has been used to photo­
graph and reproduce this manuscript from the microfilm 
master. UMI films the text directly from the original or 
copy submitted. Thus, some thesis and dissertation copies 
are in typewriter face, while others may be from any type 
of computer printer. 
The quality of this reproduction is dependent upon the 
quality of the copy submitted. Broken or indistinct print, 
colored or poor quality illustrations and photographs, 
print bleedthrough, substandard margins, and improper 
alignment can adversely affect reproduction. 
In the unlikely event that the author did not send UMI a 
complete manuscript and there are missing pages, these 
will be noted. Also, if unauthorized copyright material 
had to be removed, a note will indicate the deletion. 
Oversize materials (e.g., maps, drawings, charts) are re­
produced by sectioning the original, beginning at the 
upper left-hand corner and continuing from left to right in 
equal sections with small overlaps. Each original is also 
photographed in one exposure and is included in reduced 
form at the back of the book. These are also available as 
one exposure on a standard 35mm slide or as a 17" x 23" 
black and white photographic print for an additional 
charge. 
Photographs included in the original manuscript have 
been reproduced xerographically in this copy. Higher 
quality 6" x 9" black and white photographic prints are 
available for any photographs or illustrations appearing 
in this copy for an additional charge. Contact UMI directly 
to order. 
University Microfilms International 
A Bell & Howell Information Company 
300 North Zeeb Road, Ann Arbor, Ml 48106-1346 USA 
313/761-4700 800/521-0600 

Order Number 8920117 
Recognition of valine transfer RNA by valyl-tRNA synthetase 
from E. coli: NMR and aminoacylation studies involving wild 
type and mutant forms of 5-fluorouracil-substituted tRNA^®^ 
Chu, Wen-Chy, Ph.D. 
Iowa State University, 1989 
U M I  
300N.ZeebRd. 
Ann Arbor, MI 48106 

Recognition of valine transfer RNA by valyl-tRNA synthetase 
from E. coli: NMR and aminoacylation studies 
involving wild type and mutant forms of 
5-fluorouracil-substituted tRNA^^^ 
by 
Wen-Chy Chu 
A Dissertation Submitted to the 
Graduate Faculty in Partial Fulfillment of the 
Requirements for the Degree of 
.DOCTOR OF PHILOSOPHY 
Department: Biochemistry and Biophysics 
Major: Biochemistry 
Approved: 
Charge of Major Worl
For thfeXMajor Department 
Fo^ the Graduate College 
Iowa State University 
Ames, Iowa 
1989 
Signature was redacted for privacy.
Signature was redacted for privacy.
Signature was redacted for privacy.
il 
TABLE OF CONTENTS 
page 
ABBREVIATIONS V 
INTRODUCTION 1 
Structure and Functions of Transfer RNA 3 
General structure of transfer RNA 3 
Functions of transfer RNA 7 
5-Fluorouracil-Substituted Transfer RNAs 9 
Properties of 5-fluorouracil-substituted tRNAs 9 
^^F NMR study of 5-fluorouracil substituted tRNAs 10 
NMR studies of transfer RNA 10 
^^F NMR studies of nucleic acids 12 
^®F NMR of 5-fluorouracil substituted tRNAs 14 
Assignment of resonances in the ^^F NMR 
spectrum of (FUra)tRNA^^^ 14 
Recognition of Transfer RNA by Aminoacyl-tRNA 
Synthetases 2 0 
Characteristics of aminoacyl-tRNA synthetases 2 0 
Molecular basis of tRNA recognition by 
aminoacyl-tRNA synthetase 22 
Identity of tRNA 25 
Specificity of altered amber suppressor tRNAs 27 
In vitro transcription of tRNA 29 
EXPERIMENTAL PROCEDURES 31 
Materials 31 
Bacteria, phage strains and plasmids 31 
Restriction endonucleases and other enzymes 31 
Nucleic acids and nucleotides 32 
Miscellaneous 3 3 
iii 
page 
Methods 3 4 
Construction and cloning of tRNA^^^ gene 34 
Preparation of single-stranded DNA 35 
DNA sequence determination 36 
Oligonucleotide-directed mutagenesis 37 
In vitro transcription 37 
Fractionation of in vitro transcribed tRNA 38 
End-group analysis of in vitro transcribed tRNA 39 
Sequence of in vitro transcribed tRNA^^^ 41 
Purification of valyl-tRNA synthetase 41 
Protein determination 44 
Amino acid analysis of VRS 45 
Amino-terminal sequence determination of VRS 45 
Determination of free sulfhydryl groups 45 
Determination of ribonuclease activity 46 
Gel filtration chromatography 46 
SDS polyacrylamide gel electrophoresis 
of proteins 47 
Aminoacylation reactions 47 
Aminoacylation kinetics 48 
NMR spectroscopy 49 
RESULTS 51 
In vitro Synthesis and Characterization of 
E. coli tRNA^®^ 51 
Construction of recombinant plasmid and in 
vitro transcription of tRNA^^^ 51 
Partial characterization of the tRNA transcript 59 
Aminoacylation studies of native and in vitro 
transcribed tRNA^®^ 71 
^^F NMR spectra of in vitro transcribed 
FUra-substituted tRNA^^^ 72 
iv 
page 
Assignment of Resonances in the NMR Spectrum 
of (FUra)tRNA^®^ 78 
Site-directed mutagenesis of tRNA^^^ 78 
Assignment of FU64 in the T-stem 78 
Assignment of FU29 in the anticodon stem 84 
Assignment of FU67 in the acceptor stem 87 
Assignment of FU33 and FU34 in the 
anticodon loop 87 
Assignment of FU47 in the variable loop 92 
Assignment of FU59 in the T loop 97 
^®F NMR spectra of (FUra)tRNA^^^ mutated at 
position 8 97 
Recognition of (FUra)tRNA^^^ by Valyl-tRNA 
Synthetase 105 
Purification of valyl-tRNA synthetase from 
an overproducing strain of E. coli 105 
Partial characterization of valyl-tRNA 
synthetase 112 
Aminoacylation of mutant tRNA^^^ transcripts 118 
TO 
F NMR spectral changes induced by valyl-
tRNA synthetase binding to (FUra)tRNA^^^ 122 
DISCUSSION 128 
In vitro Transcription and Properties of 
Transcribed tRNA^^^ 128 
Assignment of Resonances in the ^®F NMR 
Spectrum of (FUra)tRNA^®^ by Base Substitution 132 
Recognition of tRNA^^^ by Valyl-tRNA Synthetase 142 
REFERENCES 150 
ACKNOWLEDGMENT 160 
V 
ABBREVIATIONS 
VRS: valyl-tRNA synthetase from E. coli 
tRNA^^^: E. coli valine transfer RNA 
FUra; 5-fluorouracil 
(FUra)tRNA^^^: 5-fluorouracil substituted E. coli tRNA^^^ 
ATP; adenosine-5'-triphosphate 
CTP: cytidine-5•-triphosphate 
GTP: guanos ine-5•-triphosphate 
UTP: uridine-5•-triphosphate 
GMP: guanosine-5'-monophosphate 
FUTP: 5-fluorouridine-5'-triphosphate 
NMR; nuclear magnetic resonance 
NOE; nuclear Overhauser effect 
ppm; parts per million 
Tris : tris[hydroxymethyl]-aminomethane 
CHES: 2-[N-cyclohexylamino]ethane-sulfonic acid 
HEPES: N-2-hydroxyethylpiperazine-N'-2-ehtanesulfonic acid 
DTT: dithiothreitol 
PMSF; phenylmethylsulfonylfloride 
DTNB: 5-5'-dithiobis-(2-nitrobenzoic acid) 
EDTA: ethylenediamine tetraacetate 
m®A; 6-methyladenosine 
m G: 7-methylguanosine 
D: dihydrouridine 
T: ribothymidine 
BSA; bovine serum albumin 
TLC: thin-layer chromatography 
SDS-PAGE; sodium dodecyl sulfate-polyacrylamide gel 
electrophoresis 
HPLC: high performance liquid chromatography 
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INTRODUCTION 
A crucial step in protein synthesis is the accurate 
incorporation of amino acids into the growing polypeptide 
chain. This is accomplished via transfer RNAs, which are 
aminoacylated with specific amino acids and through their 
adaptor function align the amino acids on the codons of 
messenger RNA. The charging of tRNAs with their cognate amino 
acids is catalyzed by aminoacyl-tRNA synthetases. There are 
20 amino acids, more than 20 tRNA species, and one synthetase 
for each amino acid in a given cell compartment. Correct 
aminoacylation of a tRNA by its cognate synthetase plays an 
important role, in the translation of genetic information. An 
understanding of the specific recognition of tRNAs by their 
cognate synthetases requires detailed knowledge of tRNA 
structure. A powerful tool widely used for monitoring the 
dynamic structure of tRNA in solution is high resolution 
nuclear magnetic resonance (NMR). 
To study the structure-function relationships of tRNA, we 
1 Q have made use of F NMR spectroscopy to probe the structure 
of tRNAs modified by incorporation of 5-fluorouracil (FUra). 
FUra-substituted valine tRNA was chosen for these studies 
because this tRNA analogue has been well characterized. Its 
biological activity and physical properties were shown to 
resemble those of the native species (Horowitz et al., 1974; 
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Ofengand et al., 1974). Fluorinated tRNA^®^ has a well 
defined NMR spectrum. Preliminary assignment of 
individual peaks in the spectrum to specific FUra residues 
within the tRNA molecule were made using variety of chemical 
and physical approaches (Gollnick et al., 1986, 1987; Hardin 
et al., 1986, 1988). However, a majority of resonances still 
remain unassigned. In this study, a new approach to 
systematically complete the assignment of F resonances in 
the spectrum of FUra-substituted tRNA^^^ was developed. 
The initial phase of the research resulted in the 
construction of a plasmid carrying the valine tRNA gene. 
Mutations were introduced into the gene by site-directed 
mutagenesis to replace individual FUra residues. Large 
quantities of 5-fluorouracil-substituted tRNA^^^ were 
synthesized in vitro by runoff transcription catalyzed by T7 
RNA polymerase in the presence of FUTP. Resonances in the 
spectrum were assigned by identifying the missing peak in the 
spectrum of the mutant (FUra)tRNA^^^. 
Structural changes in tRNA which result from specific 
mutations could be recognized by dramatic changes in the ^^F 
NMR spectra. Specific aminoacyl-tRNA synthetase recognition 
sites on the tRNA molecule could be identified from mutant 
tRNAs which lost their ability to accept valine while the 
structure of the tRNA molecule remained unperturbed. 
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Structure and Functions of Transfer RNA 
General structure of transfer RNA 
The first primary structure of tRNA, that of yeast 
tRNA^^®, was determined by Holley et al. (1965). Since then, 
more than 300 tRNAs have been sequenced (Sprinzl et al., 
1985). These tRNAs range from 75 to 90 nucleotides in length 
and have an average molecular weight of 26,000. Clark (1978) 
has reviewed the general features of the primary and secondary 
structure of tRNA. The polynucleotide chain of all tRNAs can 
be arranged in the cloverleaf secondary structure illustrated 
in Figure lA. The cloverleaf structure of tRNA consists of 4 
stems: acceptor, D, T, and anticodon stems, and 4 loops; D, 
T, anticodon, and variable (V) loops. The acceptor stem 
contains the 3* and 5' termini of the tRNA, and has the amino 
acid attachment site at the conserved 3' CCA end present in 
all tRNAs. The anticodon base triplet, located in the 
anticodon loop, carries the information to recognize the 
specific amino acid codon on mRNA during protein synthesis. 
The number of nucleotides in each stem and loop region is 
generally constant except for the V loop. Class I tRNAs 
contain 4 to 5 nucleotides in the V loop, whereas class II 
tRNAs may have up to 21 nucleotides in this loop. In 
addition, the a and 6 regions in the D loop (see Figure lA) 
vary in length from 1 to 3 nucleotides. 
Figure 1 Structure of tRNA (Kim, 1979) 
(A) Cloverleaf structure of the tRNA molecule. 
Invariant and serai-invariant positions are 
indicated by nucleotide symbols or R for 
purine, Y for pyrimidine, H for highly 
modified purine. 
(B) Schematic diagram of the tertiary 
structure of yeast tRNA^^®. The coiled tube 
represents the sugar-phosphate backbone. Base 
pairs in the stem regions are connected 
by rungs. Dark circles occupy the four 
magnesium ion binding sites. "Spaghetti" 
represents spermine molecules. 
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One of the characteristics of tRNA is the presence of 
modified nucleotides, most of which are synthesized by 
posttranscriptional modification of the parent nucleotide 
(Soli, 1971). The structure and function of these unusual 
bases have been reviewed by Nishimura (1979). There are 
invariant and semi-invariant nucleotides in some positions of 
all tRNA sequences. As indicated in Figure lA, these 
positions are often occupied by modified nucleotides and most 
of them are located in the loop regions. 
An X-ray crystallographic study of the three dimensional 
structure of yeast tRNA^^® has revealed an L-shaped molecule 
(Sussman et al., 1978; Kim et al., 1974). As shown in Figure 
IB, the polynucleotide backbone of the tRNA is folded so that 
the acceptor stem and the T stem form one continuous double-
helical arm. The D stem and anticodon stem form the other 
double-helical arm of the L-shape. The structure is about 60 
Â long, 20 A in diameter, and 80 A between the 3'-end and the 
anticodon. Tertiary interactions between the D and T loops at 
the corner of the L stablizes the molecular conformation. 
Most of the tertiary interactions involve non-Watson-Crick 
base pairs, and several of these involve bases that are 
invariant or semi-invariant in all tRNAs (Kim et al., 1974). 
The loop regions of the molecule are also stabilized by base 
stacking (Quigley and Rich, 1976). Crystal structures of 4 
other transfer RNA molecules that have been obtained support 
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the general L-shape conformation of tRNA. However, small 
conformational difference among these structures are observed 
(Woo et al., 1980; Wright et al., 1979; Westhof et al., 1985; 
Sussman and Podjarny, 1983). 
Transfer RNA structure in solution has been studied by 
several methods; chemical modification and nuclease cleavage 
patterns (Holbrook and Kim, 1983; Rich and BajBhandary, 1976), 
tritium exchange (Schimmel and Redfield, 1980), and NMR 
spectroscopy (Reid, 1981). The results of these 
investigations generally agree with the L-shape structure 
determined by X-ray crystallography. 
Functions of transfer RNA 
Translation of the nucleotide sequence of mRNA into the 
amino acid sequence of protein is mediated by transfer RNA. 
The role of tRNA in protein synthesis in bacterial systems has 
been reviewed by Pongs (1978). Transfer RNA is first charged 
with a specific amino acid by its cognate aminoacyl-tRNA 
synthetase. The aminoacyl-tRNA then forms a complex with 
elongation factor EF-Tu and GTP, and this binds to the 
ribosomal A-site during the elongation of polypeptide 
synthesis. Nucleophilic attack by the amino group of the 
aminoacyl-tRNA in the A-site on the carboxyl group of 
peptidyl-tRNA in the P-site results in peptide bond formation. 
The elongation process is repeated until one of the three 
termination codons, UAA, UGA, or UAG, appears in the A site. 
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Termination of peptide synthesis involves the deacylation of 
tRNA and the release of tRNA, mRNA and protein from the 
ribosome. 
In bacterial systems, protein synthesis is initiated by 
the binding of an initiator, tRNA formylmehtionyl-tRNA^^et 
the initiation codon of mRNA at the P-site of the ribosome. 
Methionyl-tRNA^®^ is specifically recognized and formylated 
by transformylase, with N^°-formyltetrahydrofolic acid serving 
as formyl donor (Marcker, 1965). 
Several other biological functions of tRNA such as its 
involvement in the regulation of amino acid biosynthesis, the 
regulation of amino acid transport, the regulation of the 
stringent response, and the priming of transcription by the 
reverse transcriptase of RNA tumor viruses, have been reported 
(reviewed by LaRossa and Soil, 1978). Recently Kannangara et 
al. (1988) have reported an involvement of tRNA in the 
regulation of chlorophyll biosynthesis. They found that 
chloroplast tRNA*^^^ is a cofactor in the 5-aminolevulinate 
biosynthetic pathway. A tRNA-like structure located in the 
operator region of the E. coli thrS gene was shown to be 
important in the translational regulation of threonyl-tRNA 
synthetase biosynthesis (Springer et al., 1986; Theobald et 
al., 1988). 
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5-Fluorouracil-Substituteâ Transfer RNAs 
Properties of 5-fluorouracil-substituted tRNAs 
The cytotoxic analogue of uracil, 5-fluorouracil (FUra), 
first synthesized as a drug for the chemotherapy of a number 
of cancers (Duschinsky et al., 1957), is known to be 
incorporated into DNA and cellular RNA (Major et al., 1982; 
Wilkinson et al., 1975). The effects of 5-fluorouracil on 
bacterial cells was reviewed by Heildelberger et al. (1983). 
Incorporation of this pyrimidine analogue into bacterial 
transfer RNA was first reported by Horowitz and Chargaff 
(1959). 5-Fluorouracil replaces all uracil and uracil-derived 
minor bases in these tRNAs (Horowitz and Huntington, 1967; 
Johnson et al., 1969). Unfractionated 5-fluorouracil-
containing tRNA from E. coli can be charged with all amino 
acids (Lowrie and Bergquist, 1968; Johnson et al., 1969; 
Kaiser, 1969). However, the rate of aminoacylation of 
fluorinated lysine tRNA is only 3-7% that of normal tRNA^^® 
(Ramberg et al., 1978). Aminoacylation rates of aspartyl, 
glutamyl, glutaminyl, and histidyl (FUra)tRNAs are also 
reduced (Ramberg et al., 1978). 
FUra-substituted tRNA^^^ was the first fluorinated tRNA to 
be purified (Horowitz et al., 1974) and it has been studied 
intensively. Aminoacylation kinetics determined with 
partially purified valyl-tRNA synthetase showed that both 
normal and the fluorinated tRNA^^^ have the same values 
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(Horowitz et al., 1974). Comparison of the UV-absorbance 
temperature profiles and circular dichroism spectra of normal 
and (FUra)tRNA^®^ also indicates that the structure of tRNA^^^ 
is not appreciably affected by incorporation of FUra (Horowitz 
et al., 1974). Furthermore, the ability of complex formation 
with elongation factor EF-Tu and GTP, ribosomal binding, and 
protein synthesis are all unchanged in rate and extent when 
using 5-fluorouracil-substituted tRNA^®^ in place of its 
normal counterpart (Ofengand et al., 1974). These studies 
demonstrate that 5-fluorouracil substituted tRNA^^^ is fully 
active biologically and has physical properties that resemble 
those of normal tRNA^®^. (FUra)tRNA^^^ should serve as a good 
model for the investigation of structure-function 
relationships of tRNA by ^^F NMR spectroscopy. 
^^F NMR study of 5-fluorouracil-substituted tRNAs 
NMR studies of transfer RNA High resolution nuclear 
magnetic resonance (NMR) has been used intensively to study 
the solution properties of tRNA. A majority of NMR studies on 
tRNA involve ^H NMR. This provides useful information in two 
regions of the spectrum: (a) the extreme low-field region (-15 
to -11 ppm relative to 4,4-dimethylsilapentane-l-sulfonate), 
which contains resonances from hydrogen-bonded imino protons 
(Reid, 1981), and (b) the high field region (-4 to 0 ppm), 
which has signals contributed by methyl protons from modified 
bases (Kastrup and Schimdt, 1978). Assignment of imino proton 
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via nuclear Overhauser effect (NOE) experiments provides a 
direct identification of individual resonances in the low 
field region (Roy and Redfield, 1981). Complete assignment of 
the imino protons of E. coli tRNA^^^ (Hare et al., 1985) and 
yeast tRNA^^® (Roy and Redfield, 1983; Hilbers et al., 1983) 
have been accomplished by sequential 2-dimensional NOE 
experiments. The disadvantage of using NMR for tRNA study 
is that only imino protons in base paired regions and the 
methyl groups of modified bases can be studied. This method 
can not be used to probe the structure of loop regions of the 
tRNA molecule. 
Other NMR investigations of tRNA involve and 
15N^ 31p 2fMR has been used for monitoring the conformation of 
the phosphodiester backbone of tRNA (Salemink et al., 1980; 
Gorenstein and Goldfield, 1982). NMR has been used to 
study the structure of transfer RNA labeled in the methyl 
groups of modified bases (Kopper et al., 1983; Smith et al., 
1985), or in the major base constituents (Schweizer et al., 
1984; Schmidt et al., 1983). Double resonance and two 
dimensional heteronuclear NMR studies of ^^N-labeled 
tRNA have been reported (Griffey et al., 1985). These 
techniques were applied by Roy and coworkers (1984) to assign 
imino protons in the proton NMR spectrum of yeast tRNA^^®. 
All these methods suffer from low sensitivity, and the and 
12 
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N experiments require the use of isotope enrichment 
procedures. 
NMR studies of nucleic acids The use of ^^F NMR 
in biological systems has been reviewed (Gerig, 1978; Sykes 
and Weiner, 1980). The high NMR sensitivity (83.3% of ^H), 
100% natural aboundance, large chemical shift range, and the 
extreme sensitivity of chemical shifts to the environment of 
the nucleus (Sykes and Hull, 1978; Gerig, 1978; Skyes and 
Weiner, 1980) make ^^F NMR a promising approach for the study 
of nucleic acids. In addition to the advantages mentioned 
above, ^®F NMR is well suited for studies of the interaction 
of fluorinated nucleic acids with proteins, because proteins 
will not contribute signals to the spectrum of the protein-
nucleic acid complex, simplifying interpretion of results. 
^^F NMR has been used for the investigation of structure-
function relationships of DNA oligomers containing deoxy-5-
fluorouracil in place of thymine. Kremer and co-workers 
(1987) showed that although the N-3 hydrogen bond of an A-FU 
base pair is not as stable as the corresponding hydrogen bond 
of an A-T base pair, the presence of fluorodeoxyuridine does 
not destablize helical structures. Based on their 
determination that the pKa of deoxy-5-fluorouracil in duplexes 
is similar to that of free deoxy-5-fluorouracil (Kremer et 
al., 1987) also concluded that a significant fraction of the 
FUra residues in DNA is ionized at physiological pH's. This 
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conclusion was not supported by the experiments of Sowers et 
al. (1988) and Metzler and Lu (1989), who found that the pKa 
of base-paired FUra is considerably higher than that of free 
deoxy-5-fluorouracil. The conformation of the FU-A base pair 
and the wobble FU-G base pair in helical structures was 
studied by and ^^F NMR of deoxy-5-fluorouracil-containing 
7-mer DNA duplexes. There is no structural difference between 
the T-A and the FU-A base pair, they differ only in that the 
FU-A base pair opens faster than the T-A base pair in the DNA 
duplex (Sowers et al., 1987). 
Incorporation of deoxy-5-fluorouracil into chemically 
synthesized Oj^3 DNA was reported and ^®F NMR was used for 
direct structural observation of the complex of X cro 
repressor with its specific DNA recognition sequence (Metzler 
et al., 1985; Metzler and Lu, 1989). By monitoring chemical 
shift changes of specific fluorine resonances on protein 
binding, Metzler et al. (1985) were able to confirm cro 
binding to one face of the DNA duplex as predicted by a model 
of cro repressor-0jj3 operator binding based on the three 
dimensional structure of cro repressor (Ohlendorf et al., 
1982). Metzler and Lu (1989) reported that binding of protein 
induces distortions in the operator DNA which was not proposed 
in the model (Metzler and Lu, 1989). In an example of ^®F NMR 
studies with fluorine-labeled RNA, Marshall and Smith (1980) 
used ^®F-^H NOE methods to examine the structure of 5-
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fluorouracil substituted E. coli 5S ribosomal RNA and showed 
that the molecule in solution is highly rigid. 
The successful purification of 5-fluorouracil-
substituted E. coli tRNAs broadened the area of transfer RNA 
1 Q 
research by permitting the use of F NMR spectroscopy. 
NMR of 5-fluorouracil substituted tRNAs ^^F NMR 
spectroscopy provides a powerful tool for probing the solution 
structure of FUra-substituted tRNA. Spectra of three purified 
5-fluorouracil-substituted tRNAs from E. coli. tRNA^^^, 
tRNA^®^ and tRNA™^®^, have been reported (Horowitz et al., 
1977; Hills et al., 1983; Hardin et al., 1988). ^®F NMR 
spectra of (FUra)tRNAs recorded at 282 MHz, in pH 6.0 buffer 
containing 15 mM MgClg and 100 mM NaCl show 12 resolved peaks 
for the 14 incorporated FUra in fluorinated tRNA^^^ (see 
Figure,13 in Results), 13 resolved resonances from the 18 
incorporated FUra residues in (FUra)tRNA™^®^ (Hardin et al., 
1988), and 9-10 resolved resonances derived from the 12 FUras 
in (FUra)tRNA(Hardin et al., 1988). ^^F NMR spectral 
changes of (FUra)tRNA^^^ induced by termperature, ionic 
strength, pH effects (Hardin et al., 1986) and codon binding 
to tRNA (Gollnick et al., 1986) have been determined and will 
be discussed later in this chapter. 
Assignment of resonances in the ^^F NMR spectrum of 
(FUra)tRNA^^^ There are 14 ^^F probes, distributed 
throughout all stems and loops of the (FUra)tRNA^^^ molecule 
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(Figure 2). After all peaks are assigned, these probes can 
serve as site-specific reporters for monitoring all parts of 
the tRNA molecule simultaneously by NMR spectroscopy. 
The multiplicity of resonances in the ^®F NMR spectrum of 
(FUra)tRNA^®^ are due to the higher order structure of the 
tRNA molecule. After thermal denaturation of tRNA all 
resonances in the spectrum collapse and form a single peak 
centered at 4.7 ppm downfield from free FUra (Hardin et al., 
1988). The ^^F NMR spectrum of poly(FU), which exists as a 
random coil under the experimental conditions used (Szer and 
Shugar, 1963; Massoulie et al., 1963), shows a single peak at 
4.5 ppm. These results indicate that resonances in the 
central region of the ^^F NMR spectrum belong to FUra residues 
in loops (nonhydrogen-bonded bases) of the (FUra)tRNA^^^ 
molecule. 
Additional support for this conclusion comes from an 
investigation of the solvent isotope effect. Resonances in 
the central region of the spectrum shift upfield when the tRNA 
is transferred from HgO to DgO (solvent isotope shift, SIS), 
indicating that FUra residues which have chemical shifts in 
this region have the greatest degree of solvent exposure 
(Hardin et al., 1986). Study of the pH dependence of the ^®F 
NMR spectrum of (FUra)tRNA^^^ shows that the resonances 
between 4 to 4.5 ppm shift downfield as pH increases. Peaks 
C, D, E, F and H are accessible to titration between pH 4.5 
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Figure 2 cloverleaf structure of E. coli tPNA with uracil 
and uracil-derived bases replaced by 5-fluorouracil 
(F) Bases which are invariant in all tRNAs are 
enclosed in boxes. Tertiary base pairs involving 
5-fluorouracil are connected by solid lines. 
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and 9 and have pKa's close to that of free 5-fluorouridine 
(Hardin et al., 1986). Reaction of (FUra)tRNA^^^ with 
bisulfite, a reagent which preferentially reacts with 
pyrimidines in single-stranded regions of tRNA (Furuichi et 
al., 1970; Shapiro et al., 1970; Schulman and Pelka, 1977), 
results in 35 to 40 ppm upfield shifts of peaks D, E, F and H 
as a result of the formation of a bisulfite adduct with 5-
fluorouracil (Sander and Deyrup, 1972). All these results 
provide a firm basis for assigning peaks in the central region 
of the ^^F spectrum of fluorinated tRNAs to FUra residues in 
loop regions of the molecule. 
Evidence for assigning upfield resonances to FUra 
residues which are involved in double-stranded helical regions 
of the tRNA comes from a study of psoralen intercalation into 
tRNA. Psoralen derivatives are known to react, through 
cyclophotoaddition, with pyrimidines in double-stranded 
regions of nucleic acids (Ou and Song, 1978; Bachellerie and 
Hearst, 1982). Reaction of (FUra)tRNA^^^ with 4'-
(hydroxymethyl)-4,5',8-trimethylpsoralen causes a decrease in 
intensity of peaks I throuth L in the upfield region of the 
spectrum of (FUra)tRNA^^^ (Hardin et al., 1986), supporting 
the assignment of the resonances in this region to FUra 
involved in secondary hydrogen-bonded interactions. 
Peaks A and B in the downfield region of the ^^F NMR 
spectrum of (FUra)tRNA^^^ were tentatively assigned by 
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indirect methods to FUSS and 54, respectively (Horowitz et 
al., 1977; Hardin et al., 1988). A reciprocal nuclear 
Overhauser effect was observed between peak A and peak B 
(Hardin et al., 1988). Assuming that (FUra)tRNA^^^ has a 
structure similar to that of yeast tRNA^^®, only the 5-
fluorouracils at positions 54 and 55 are close enough to give 
an appreciable ^®F-^®F nuclear Overhauser effect. A 
temperature-dependent splitting of peak B was observed in the 
spectrum of (FUra)tRNA^^^ (Hardin et al., 1988). This effect 
is similar to the splitting of T54 methyl ^H and signals 
in the spectra of several native tRNAs (Kastrup and Schmidt, 
1978; Kopper et al., 1983). Peak B was, therefore, assigned 
to FU54 and peak A was assigned to FUSS. The latter 
assignment is supported by the observation that peak A has a 
unique large chemical shift change with changing ionic 
strength and magnesium ion concentration in all three 
fluorinated tRNAs studied (Hardin et al., 1988), indicating 
peak A is derived from a FUra at an invariant position in the 
tRNA. The assignment of peak B to FU54 has been shown to be 
incorrect in the work reported here. 
Three additional resonances have been assigned by various 
approaches. Two isoacceptor species of (FUra)tRNA^^^, forms A 
and B, have been isolated (Hardin et al., 1988). They differ 
in the D loop, position 17 of form A is a fluorodihydrouracil 
derivative, while form B has a fluorouracil at this position 
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(Hills et al., 1983; Hardin et al., 1988). A resonance at 4.5 
ppiti (peak D) in the spectrum of form B is shifted upfield to -
15 ppm in the spectrum of form A (Hardin et al., 1988). This 
permits assignment of peak D (at 4.5 ppm) to the FUra residue 
at position 17 in (FUra)tRNA^®^. This position is occupied by 
dihydrouridine in normal tRNA^®^. 
Study of the changes in the NMR spectra of 5-
fluorouracil substituted tRNAs due to oligonucleotide codon 
binding to the anticodon has allowed two positions in 
(FUra)tRNA^^l, FU33 and FU34, to be assigned (Gollnick et al., 
1986; 1987). Binding of the trinucleotide GUA to 
(FUra)tRNA^®^ results in the upfield shift of the ^^F 
resonance at 3.9 ppm (Peak H). Addition of the 
tetranucleotide GUAA shifts two peaks, F and H. As a result, 
peak H was assigned to FU34, at the 5' position of the 
anticodon, and peak F to FU33, 3' adjacent to the anticodon of 
(FUra)tRNAVal. 
Assignment of resonances in the ^^F NMR spectrum of 
(FUra)tRNA^®^ must be completed in order to interpret ^^F NMR 
studies of tRNA structure in solution and the interaction of 
tRNA with biologically relevant molecules. 
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Recognition of Transfer RNA by Aminoacyl-tRNA Synthetases 
Characteristics of aminoacvl-tRNA synthetases 
Aminoacyl-tRNA synthetases are a group of enzymes which 
participate in the first step of the protein biosynthetic 
pathway. Each synthetase catalyzes the attachment of a 
specific amino acid to the 3' end of its cognate tRNA. The 
general features and structure-function relationships of the 
synthetases in the recognition of transfer RNAs were reviewed 
by Schimmel and Soli (1979) and later by Schimmel (1987). 
Although these enzymes catalyze similar reactions, the 
molecular weight and structure of different synthetases are 
variable. Schimmel and Soil (1979) summarized the properties 
of the aminoacyl-tRNA synthetases that had been purified at 
that time. The types of subunit structure include a, a2, 0:4 
and a262. Complete amino acid sequences of at least 25 , 
aminoacyl-tRNA synthetases from different sources have been 
published (Schimmel, 1987; Heck and Hatfield, 1988). The size 
of the polypeptide chains range from 327 amino acids for the 
Bacillus stearothermophilus tryptophan enzyme (Winter and 
Hartley, 1977) to 939 amino acids for the E. coli isoleucine 
enzyme (Webster et al., 1984). 
Sequence homologies between synthetases have been found 
(Schimmel et al., 1982; Kohda et al., 1984; Berg, 1986; Heck 
and Hatfield, 1988). The consensus sequence, HIGH, which 
is located near the amino-terminal of all known aminoacyl-tRNA 
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synthetases, is believed to be the ATP binding site (Berg, 
1986). Homologus sequences, K M S K S, shared by many 
synthetases, are reported to be involved in the binding of the 
3' end of the tRNA molecule (Kohda et al., 1984). Schimmel 
(1987) proposed a general scheme for the structural 
organization of aminoacyl-tRNA synthetases in terms of 
functional units along the amino acid sequence. His 
suggestion that the site of aminoacyl-adenylate synthesis is 
located in the amino terminal half of the enzymes and is 
followed by the tRNA binding domain, has been shown to hold 
for the E. coli alanine (Jasin et al., 1983), glutamine 
(Webster et al., 1984), isoleucine (Webster et al., 1984; 
Hountondji et al., 1985), methionine (Rislerr et al., 1981; 
Blow et al., 1983; Hountondji et al., 1985; Valenzuela and 
Schulman, 1986), and tyrosine (Waye et al., 1983; Blow et al., 
1983) enzymes. The biological function of the large, 
dispensable, sequences in the C-terminal region of the 
synthetases is still unclear. The C-terminal end of E. coli 
alanyl-tRNA synthetase was shown to be involved in the 
oligomerization of this o4 enzyme (Jasin et al., 1984). 
X-ray crystallographic studies of several aminoacyl-tRNA 
synthetases have been reported. The 3-dimensional structures 
of tyrosyl-tRNA synthetase from Bacillus stearothermophilus 
(Bhat et al., 1982), and of the biologically active 
proteolytic fragment of methionyl-tRNA synthetase from E. coli 
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(Zelwer et al., 1982) have been solved. The X-ray diffraction 
pattern of yeast aspartyl synthetase shows that this molecule 
has an elongated shape (Dietrich et al., 1980). Recently, the 
structure of yeast glutamyl-tRNA synthetase complexed with 
tRNA®^^ has been determined (Perona et al., 1988b). 
In spite of the vast amount of research done on the 
structure-function relationship of aminoacyl-tRNA synthetases, 
especially their specific recognition of transfer RNA, this 
still remains a challenging topic of study. 
Molecular basis of tRNA recognition by aminoacvl-tRNA 
synthetase 
Specific recognition of tRNA by aminoacyl-tRNA synthetase 
has long been studied. A review by Schimmel and Soli (1979) 
summarizes the approaches that have been undertaken to 
investigate this question. These include aminoacylation 
studies of chemically modified, mutant, or dissected tRNAs, 
protection of tRNA against nuclease digestion by synthetase 
binding, and direct mapping of the contact points by 
photochemical cross-linking of tRNA and synthetase. These 
methods are still useful tools for studying tRNA-synthetase 
interactions and are still widely employed by numerous 
investigators. 
One of the tRNA-synthetase complexes that has been 
studied in detail is that of E. coli formyl-methionine tRNA 
and methionyl-tRNA synthetase. The structural requirements of 
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tRNA^®^ for aminoacylation by this synthetase have been 
reviewed by Schulman (1979). By examining the effect of 
methionyl-tRNA synthetase in protecting tRNA^®^ against 
chemical modification and enzymatic cleavage, it was shown 
that the anticodon of tRNA^^®^ is the major site of 
recognition (Pelka and Schulman, 1986; Schulman et al., 1983). 
Similar approaches were taken to map the synthetase 
recognition regions of yeast tRNA^^®, tRNA^^^ and E. coli 
tRNA®^^, tRNA^®^, tRNA®*"®^, tRNA^^® (Vlassov et al., 1981, 
1983), beef tRNA'^^P (Garret et al., 1984), yeast tRNA^^P 
(Romby et al., 1985) and E. coli tRNA*^^^ (Theobald et al., 
1988). The site of synthetase interaction with tRNA 
determined in these studies generally agrees with the model 
proposed by Rich and Schimmel (1977), which will be discussed 
later. 
The most direct way to study the synthetase-tRNA complex 
is to obtain detailed structure by X-ray diffraction analysis. 
However, the difficulty of cocrystallization of synthetase and 
tRNA has slowed progress in this area. The first crystals of 
a synthetase-tRNA complex, that of yeast aspartyl-tRNA 
synthetase and tRNA^®P, which diffracts to 7.5 A, was reported 
by Lorber et al. (1983). These crystals gave only a low 
resolution structure (Podjarny et al., 1987). Perona and 
coworkers (1988a) have recently described crystals of E. coli 
glutaminyl-tRNA synthetase complexed with tRNA®^^ which 
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diffract to 2.8 A. The X-ray structure of these crystals 
revealed that the synthetase binds over the entire region 
along the inside of the L-shaped tRNA molecule and that the 
binding of synthetase induces a conformational change at the 
end of the acceptor stem of tRNA®^^ (Perona et al., 1988b). 
A steady-state fluorescence study of tRNA^®^ labeled 
with a fluorphore has been reported by Ferguson and Yang 
(1986a, 1986b). These experiments indicate a conformational 
change at the 3' end of the tRNA^®^ molecule upon binding of 
methionyl-tRNA synthetase. In addition to the fluorescent 
labeling of tRNA, the natural occurring flouorphore, Y base in 
yeast tRNA^^® (Ehrlich et al., 1980), has provided a way to 
study tRNA-synthetase interaction by fluorimetric methods. 
Although NMR spectroscopy has been widely used to 
probe the dynamic structure of tRNA in solution, very few NMR 
studies of tRNA-synthetase interactions have been reported. 
The reason, in part, is the fact that proteins contribute 
large numbers of proton signals to the proton NMR spectrum. 
It is, therefore, difficult to identify signals contributed by 
tRNA molecule in the complex. Schulman and coworkers (1974) 
studied the NMR spectrum of E. coli tRNA®^^ complexed with 
glutamyl-tRNA synthetase and observed a broadening of 
individual resonances from 45 Hz in the absence of protein to 
150 Hz in the presence of an equal molar amount of synthetase. 
A NMR study of the interaction between B. 
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stearothermophilus valyl-tRNA synthetase and E. coli tRNA^^^ 
labeled with at the carbonyl C4 of uracils and uracil-
derived minor bases has been reported (Schweizer et al., 
1984). This enzyme was shown to be in contact with the 
anticodon, D and T loops of tRNA^^^. In the meantime, studies 
of the interaction between synthetase and 5-fluorouracil-
substituted tRNA by NMR spectroscopy are underway in this 
laboratory. 
A general model for the interaction of a tRNA and with 
its cognate aminoacyl-tRNA synthetase was proposed by Rich and 
Schimmel (1977). As illustrated in Figure 3, this model 
postulates that the synthetase binding site is located along 
and around the inside of the L shaped tRNA structure. Regions 
of tRNA involved in synthetase binding are the amino acid 
acceptor stem, the dihydrouridine stem, and the anticodon. 
Depending on the enzyme and tRNA, this recognition site may 
involve only the acceptor stem, or it may extend all the way 
down to the anticodon. 
Identitv of tRNA 
More than 300 tRNAs have been sequenced so far (Sprinzl 
et al., 1985). Based on the chemical and physical studies 
outlined above, all these tRNAs are believed to have similar 
secondary and tertiary structures. What factors permit a 
synthetase to distinguish among the different tRNAs? It is 
believed that there are distinguishing features in each tRNA 
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Figure 3 A proposed model of the interaction of tRNA with 
the surface of synthetase (Rich and Schimmel, 
1977) The tRNA molecule shown here is based on 
the t&ree dimensional crystal structure of yeast 
tRNA . The dashed lines (A-C) represent three 
different synthetase surfaces in contact with 
different sizes of recognition region on tRNA. 
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which are responsible for the amino-acid specificity. The 
advent of methods for the ready synthesis of oligonucleotide 
and genetic cloning techniques opened a new era in research on 
tRNA-synthetase recognition. The term "tRNA identity" is now 
commonly used to describe tRNA features that are recognized by 
one aminoacyl-tRNA synthetase and yet prevent its recognition 
by other synthetases. 
Two approaches have been taken to study the identity of 
tRNAs. Both methods involve the genetic engineering of tRNA 
genes in vitro to produce mutants at specific positions in the 
tRNA molecule. Recognition of tRNA by synthetase is then 
determined by either examining the function of mutant amber 
suppressor tRNAs in vivo, or by aminoacylation studies of 
mutated tRNAs transcribed in vitro. 
Specificity of altered amber suppressor tRNAs An 
amber suppressor tRNA carries the CUA anticodon which can 
recognize the amber codon UAG. Normanly and coworkers (1986) 
determined the in vivo suppressing activity of several 
suppressor tRNA^®^ mutants and found that by changing 12 
nucleotides in the sequence, the tRNA was transformed from a 
leucine suppressor to a serine suppressor. This pioneering 
research has led to the study of tRNA identity by in vivo 
assays of amber suppressor tRNA activity. In this approach, a 
mutant dihydrofolate reductase gene was constructed. In this 
construct, the gene coding for the amino acid at position 10 
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near the N-terminus of dihydrofolate reductase was replaced by 
an amber codon (CUA) (Normanly et al., 1986). Dihydrofolate 
reductase is a protein of 159 amino acid residues (Smith and 
Calvo, 1981). A simple affinity chromatography procedure for 
the purification of this protein from overproducing strain of 
E. coli has been established (Baccanari et al., 1981). The 
amino acid specificity of mutant suppressor tRNAs was 
determined by examining the identity of the amino acid 
inserted at the amber site at position 10 of dihydrofolate 
reductase by amino acid sequence analysis. By using this 
approach, the nucleotides responsible for determining the 
identity of several tRNAs have been described (for a summary, 
see Schulman and Abelson, 1988). 
It was shown that the G-U wobble pair at position 3-70 of 
the acceptor stem of E. coli tRNA^^® is the major site of 
identity of this tRNA (Hou and Schimmel, 1988; McClain and 
Foss, 1988a; Park and Schimmel, 1988). McClain et al. (1988) 
have recently shown that the G-U wobble pair induces a 
structural irregularity in the acceptor helix of tRNA^^^. It 
is this structural feature that is responsible for the alanine 
acceptor identity. Involvement of the acceptor stem in tRNA 
identity has also been reported for E. coli tRNA^^^ (Rogers 
and Soil, 1988). The specificity of tRNA^^^ and tRNA^^® from 
E. coli have been identified by similar studies. The identity 
of tRNA^^^ is determined by a "variable pocket" comprised of 
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residues 16, 17, 20, 59 and 60, on the surface of the tRNA 
molecule (McClain and Foss, 1988b). In E. coll tRNA^^®, 
nucleotides located at the corner of the L-shape tRNA 
structure are important for identity (McClain and Foss, 
1988c). 
The advantage of using the in vivo system to study tRNA 
specificity is that the effects of competition among all 
aminoacyl-tRNA synthetases for a given substrate are 
determined. However, this method suffers from the 
disadvantage that it requires replacing the anticodon of all 
tRNAs by CUA which recognizes the amber codon. Those tRNAs 
whose synthetase recognition site includes the anticodon 
cannot be investigated by this approach. The in vitro 
synthesis of tRNA, as described by Sampson and Uhlenbeck 
(1988), provides an alternative method for determination of 
tRNA identity. 
In vitro transcription of tRNA A major advance in 
the in vitro synthesis of RNA is the use of phage promoters 
and phage RNA polymerases (Melton et al., 1984). This method 
has recently been applied to the synthesis of oligonucleotides 
from synthetic DNA templates by TV RNA polymerase (Milligan et 
al., 1987) or SP6 RNA polymerase (Sharmeen and Taylor, 1987). 
Sampson and Uhlenbeck (1988) have extended the procedure to 
the synthesis of an unmodified tRNA by runoff transcription 
from a synthetic DNA template. In this method, a synthetic 
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yeast tRNA^^® gene is linked directly to the T7 RNA polymerase 
promoter. The construct can be readily amplified by insertion 
into an appropriate plasmid. Digestion with BstNl provides 
the template for runoff transcription, and yields tRNA with 
the proper 3'-CCA end group. The unmodified tRNA^^® 
synthesized by this method was shown to resemble the native 
species in both aminoacylation activity and tertiary structure 
folding (Sampson and Uhlenbeck, 1988). With the development 
of the in vitro transcription system, mutations can be 
introduced into the tRNA gene and the specificity of the 
transcribed tRNA can be monitored by study of the kinetics of 
aminoacylation by cognate and noncognate synthetases. 
Using this method, Sampson and coworkers showed that five 
nucleotides in the single-stranded regions of yeast tRNA^^®, 
G20, G34, A35, A36 and A73, are required for recognition by 
yeast phenylalanyl-tRNA synthetase (Sampson et al., 1989). 
Schulman and Pelka (1988), using the same approach, reported 
that switching the anticodon between E. coli methionine and 
valine tRNAs interchanges the identity of these two tRNAs. 
Both studies showed the involvement of the anticodon in the 
recognition of these tRNAs by their cognate synthetase. 
These studies indicate that only a small number of 
nucleotides are required to identify a tRNA. Research toward 
determining the identifying features of all 20 tRNAs is 
continuing. 
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EXPERIMENTAL PROCEDURES 
Materials 
Bacteria, nhaae strains and plasmids 
E. coli TGI (K12, 4[lac-pro], SupE, thi, hsdD5/F'traD36, 
ProA+B+, lacl^, lacZ M15), used as the host for transformation 
by plasmid DNA, was obtained from Amersham. Bacteriophage 
M13K07 and plasmid pUC119 were gifts of Dr. Alan Myers (Iowa 
State University). E. coli GRB238, containing plasmid pHOVl 
(Skogman and Nilsson, 1984), used for the preparation of 
valyl-tRNA synthetase, was kindly donated by Dr. George L. 
Marchin of Kansas State University. 
Restriction endonucleases and other enzvmes 
Restriction endonucleases were obtained from New England 
Biolabs, Bethesda Research Laboratories or American Allied 
Biochem and used according to the manufacturer's instructions. 
Inorganic pyrophosphatase and phosphodiesterase were from 
Boehringer Mannheim. Bacterial alkaline phosphatase was 
purchased from Bethesda Research Laboratories. T4 RNA ligase 
and RNase T1 were the products of Pharmacia Biochemicals. 
Polynucleotide kinase was from New England Biolabs. RNase T2 
was obtained from Sigma. T7 RNA polymerase used for 
transcription of tRNA was prepared from E. coli BL21/pAR1219 
(Davanloo et al., 1984) according to the method of Dunn et al. 
(Brookhaven National Laboratory, Upton NY; personal 
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communication). Twenty-five mg of the enzyme, specific 
activity 1.14x10® units/mg, were obtained from 17 g of wet 
cells. Units of enzyme were defined by comparison with the 
activity of commercial T7 RNA polymerase (New England Biolabs) 
in incorporation of [a-^^P]ATP into tRNA^^^ (see "in vitro 
transcription" under Methods). 
Nucleic acids and nucleotides 
E. coli tRNA^®^ was obtained from Subriden RNA. 
Unfractionated E. coli tRNA was from Plenum Scientific 
Research Inc. (FUra)tRNA^®^ was purified from FUra-grown 
E. coli B cells as described by Hardin et al. (1986). ATP, 
UTP, GTP and CTP were all from United States Biochemical Co. 
FUTP was purchased from Sierra Bioresearch. 5*-GMP and 3'-CMP 
were from Sigma. [T-^ ^P]ATP (3000 Ci/mmole, 10 mCi/ml) and 
[a-32p]GTP (800 Ci/mmole, 10 mCi/ml) were both from New 
England Nuclear Research. Radioactive pCp was prepared from 
[T-32p]ATP and 3*-CMP according to England et al. (1980). A 
reaction mixture containing 1 mM 3'-CMP, 25mM potassium-CHES 
pH 9.5, 5 mM MgClg, 3 mM DTT, 50 jug/ml BSA, 5 jUM [T-^^P]ATP 
and 10 units of T4 polynucleotide kinase in a total volume of 
50 nl was incubated at 37"C for 90 minutes. This mixture was 
analyzed by thin layer chromatography on polyethyleneimine 
plates (Macherey-Nagel Co.) developed with 0.8 M ammonium 
sulfate; all of the radioactive material was converted into a 
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single product, [5'-^^P]pCp, which was stored at -20°C and 
used directly for 3'-end labeling of tRNA. 
Oligonucleotides were synthesized on a Biosearch 8750 DNA 
synthesizer by the Nucleic Acid Facility at Iowa State 
University. HPLC purified oligonucleotides were detritylated 
by hydrolysis with 80% acetic acid and further purified on a 
C18 Sep-Pak column (Applied Biosystem, 1984). 
Miscellaneous 
Sêpharose 4B, phenylmethylsulfonylfloride, 5-5'-
dithiobis-(2-nitrobenzoic acid), protein standards for 
molecular weight determination, ampicillin, kanamycin, 
spermidine, tris[hydroxymethyl]-aminomethane, 2-[N-
cyclohexylamino]ethane-sulfonic acid, N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid, BSA, agarose, 
urea, sodium cacodylate were all purchased from Sigma. 
Acrylamide and N,N-methylene bisacrylamide were also from 
Sigma and were purified by stirring a 40% solution with the 
mixed-bed resin MB-3 (Mallinckrodt), as described by Maniatis 
et al. (1983). Dithiothreitol was obtained from CalBiochem. 
Affi-Gel Blue, hydroxyapatite and Bradford protein assay 
reagent were purchased from Bio-Rad Laboratories. Ammonium 
sulfate (ultrapure) was the product of Schwarz/Mann. 
[^^C]valine (225 Ci/mole, 100 pCi/ml) and [^H]valine (25 
Ci/mmole, ICi/ml) were bought from ICN Biomedicals, Inc. and 
Amersham Corporation respectively. 5-Fluorouracil was a gift 
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from Hoffmann-La Roche Inc. DgO was from Norell Inc. Cell 
growth media were from Difco or Fisher Chemical Co. Other 
reagents were of analytical grade or higher. 
Methods 
Construction and cloning of tRNA^^^ aene 
Plasmid pVAL119-21 was constructed by ligation of a 105 
base paired synthetic DNA fragment, containing the tRNA^^^ 
gene sequence directly linked to a T7 RNA polymerase promoter, 
into the EcoRI/BamHI site of pUC119. For preparation of the 
105 base paired DNA, six oligonucleotides as shown in Figure 5 
were synthesized. The four internal oligonucleotides were 5'-
phosphorylated in a 300 /il reaction mixture containing 10 fig 
of each DNA fragment, 70 mM Tris-HCl, pH 7.6, 10 mM MgClg, 5 
mM DTT, 0.1 mM ATP, 0.3 mM spermidine and 100 units T4 
polynucleotide kinase. After incubation at 37°C for 1 hour, 
unreacted ATP was separated from DNA by passing the reaction 
mixture through a Sephadex G-50 column (Maniatis et al., 1983) 
and kinase was removed by phenol extraction. The 
phosphorylated oligonucleotides were combined with the two 
external fragments in 35 mM Tris-HCl buffer, pH 7.5, 
containing 13 mM MgClg, and the mixture was annealed by 
incubation at 65"C for 5 minutes followed by slow cooling to 
room temperature. Ligation was carried out at 16°C for 16 
hours in a 30 jul reaction mixture containing 20 mM Tris-HCl, 
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pH 7.5, 7.5 mM MgClg, 1 mM ATP, 10 mM DTT, 0.05 itig/ml BSA and 
40 units of T4 DNA ligase. The resulting 105 bp DNA was 
purified by electrophoresis on a 6% polyacrylamide gel (10 x 
15 X 0.15 cm). DNA was eluted from the gel by soaking in 0.5 
M ammonium acetate buffer, pH 8.0, 1 mM EDTA overnight at 37°C 
(Maniatis et al., 1983). This 105 base paired oligonucleotide 
was not 5•-phosphorylated to prevent self-ligation during its 
insertion into plasmid. Plasmid pUC119 was digested with 
EcoRI and BamHI. The restricted DNA was purified by 
electrophoresis on a 1% agarose gel and recovered by 
electroelution (Maniatis et al., 1983). The synthetic 105 bp 
oligonucleotide was then ligated into the vector by T4 DNA 
ligase and the ligation mixture used to transform E. coli TGI. 
Recombinant plasmid was selected by screening for the presence 
of the 105 base pair EcoRI/BamHI restriction fragment insert 
and its sequence was confirmed by dideoxy DNA sequencing of 
the DNA. 
Preparation of sinale-stranded DNA 
Single-stranded pUC119-derived DNA for sequence analysis 
and oligonucleotide-directed mutagenesis was prepared as 
described by Vieira and Messing (1987). Ten ml of 2XYT medium 
(Maniatis et al., 1983) containing 40 ng/ml ampicillin was 
inoculated with E. coli TGI carrying the recombinant pUC119 
plasmid and shaken at 37"C until the culture reached early log 
phase, usually 30 minutes. The culture was then infected with 
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helper phage Ml3KO7 at a multiplicity of infection of 2-10 
(Vieira and Messing, 1987). After a further 30 minutes 
incubation at 37°C, the infected culture was diluted 1 to 10 
with fresh 2XYT medium containing 40 fig/ml ampicillin and 70 
Mg/ml kanamycin and allowed to grow overnight at 37°C. The 
supernatant of the overnight culture was collected by 
centrifuging twice at 5K rpm for 5 minutes in a Beckman JA-20 
rotor and phage particles were precipitated from the 
supernatant by addition of 2.5 ml of 20% polyethylene glycol 
containing 2.5 M NaCl. The pellet, collected by 
centrifugation at lOK rpm for 10 minutes in a Beckman JA-20 
rotor, was redissolved in 300 nl TE buffer (10 mM Tris-HCl pH 
8.0, 1 mM EDTA) and treated twice with an equal volume of 
water-saturated phenol and 3 times with ether. Finally, the 
DNA was ethanol precipitated and dissolved in 50 jul of water. 
The yield of single-stranded DNA by this procedure is usually 
50 i ig .  
DNA sequence determination 
The sequence of the single-stranded DNA was determined by 
the dideoxy method of Sanger (Sanger et al., 1980), utilizing 
^^S-labeled dATP (Amersham SJ304) and a M13-17mer universal 
primer. Sequencing reactions were carried out according to 
the Amersham M13 cloning and sequencing handbook. 
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• Oliaonucleotide-directed mutagenesis 
Oligonucleotide-directed mutagenesis of the cloned 
Val tRNA gene was performed by the method of Eckstein (Taylor 
et al., 1985) using the site-directed mutagenesis kit from 
Amersham (#RPN 2322). Mutation was directed by a synthetic 
oligonucleotide synthesized by the Nucleic Acids Facility at 
Iowa State University. Mutants were selected by DNA 
sequencing. 
In vitro transcription 
Recombinant plasmids used for in vitro, transcription were 
purified by cesium chloride density gradient 
ultracentrifugation (Maniatis et al., 1983). The plasmid was 
digested by BstNl to provide a linear template. 
Runoff transcription was carried out according to Sampson 
and Uhlenbeck (1988) in a reaction mixture containing 80 ixg/ml 
BstNl-digested pVAL119-21, 4 mM each of ATP, CTP, GTP and UTP 
(FUTP replaced UTP for the synthesis of 5-fluorouracil-
substituted tRNA^^^), 40 mM Tris-HCl, pH 8.1, 22 mM MgClg, 2 
mM spermidine, 5 mM DTT, 50 /xg/ml BSA, 80 units/^1 of T7 RNA 
polymerase and 4 units/ml of inorganic pyrophosphatase. After 
incubation for 2 hours at 42°C, the reaction was stopped by 
addition of EDTA to a final concentration of 50 mM. The 
reaction mixture was extracted first with an equal volume of 
phenol/chloroform/isoamyl alcohol (25:24:1) followed by an 
extration with chloroform/isoamyl alcohol (24:1). 
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Transcription products were then precipitated with ethanol and 
the pellet was redissolved in 100 jitl of TM2 (10 inM Tris-
Acetate, pH 7.4, 10 mM MgfOAclg). 
The tRNA transcript was subjected to chromatography on a 
Toyopearl DEAE-650S HPLC column (250x4.6 mm). HPLC 
chromatography was carried out on a Beckman HPLC system which 
included two Beckman llOB pumps, a model 406 analog interface 
module and a model 116 programmable detector. The Toyopearl 
DEAE-650S column was first equilibrated with 25 mM Tris-HCl, 
pH 7.0, containing 250 mM NaCl. After injection of the 
sample, the column was washed with 350 mM NaCl in the same 
buffer and RNA eluted with a linear gradient of NaCl from 3 50 
to 600 mM (0.5 ml/min; 40 min). Material from a 2-3 ml 
transcription reaction could be applied to the column. The 
tRNA-containing fractions were pooled and the tRNA ethanol 
precipitated. 
Fractionation of in vitro transcribed tRNA 
Transfer RNA transcribed in vitro by T7 RNA polymerase is 
heterogeneous (see Results). The mixture could be resolved by 
chromatography on a Gen-Pak FAX HPLC column (Waters). After 
applying the sample, the column was washed with 25 mM Tris-
HCl, pH 7.5, containing 400 mM NaCl. RNA was then eluted with 
a linear NaCl gradient from 400 mM to 600 mM in the same 
buffer (0.5 ml/min; 30 min). 
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End-group analysis of in vitro transcribed tRNA 
In vitro transcribed tRNA^^^ was purified for 5'- and 3'-
end group analysis by electrophoresis on a 15% 
polyacrylamide/SM urea gel (15 x 20 x 0.15 cm). After 
staining the gel with ethidium bromide, the band which 
comigrated with purified E. coli tRNA^^^ was cut out, the gel 
crushed with a baked glass rod, and soaked in an equal volume 
of soaking buffer (50 mM potassium acetate, 20 mM EDTA, 200 mM 
KCl) for 48 hours at 4°C. Polyacrylamide was removed by 
passing the sample through an empty Quick-Sep column (Isolab, 
Inc.) and the extracted tRNA was ethanol precipitated. 
The purified transcript was 5'-end labeled with r-^^P-ATP 
and polynucleotide kinase as described by England et al. 
(1980). 3'-end labeled tRNA was prepared by reaction with 
[5i_32p]pcp and T4 RNA ligase (England et al., 1980). Labeled 
tRNA was purified by electrophoresis on a 15% 
polyacrylamide/8M urea gel (150 x 200 x 1.5 mm) and was 
recovered from the gel by crushing and soaking the gel at 4°C 
overnight in elution buffer consisting of 500 mM ammonium 
acetate, 0.1% SDS, 0.001% Triton X-100 and 40 ^g/ml unlabeled 
carrier tRNA (Gollnick, 1986). 
The 5'- and 3'-terminal residues of the in vitro 
transcripts were determined by thin layer chromatography of 
nuclease digests of end labeled tRNA. 5'-end labeled tRNA was 
digested for 2 hours at 37°C with 0.5 ^ig of snake venom 
40 
phosphodiesterase in 5 /il of 50 mM Tris-HCl, 5 mM potassium 
phosphate buffer, pH 8.9, containing 0.2 ug carrier tRNA. 
RNase T2 digestion of 3•-end labeled tRNA and tRNA labeled by 
[a-^^P]GTP was carried out in a 5 jul reaction mixture 
containing 20 mM ammonium acetate pH 4.5, 0.4 ^ g of carrier 
tRNA and 0.1 unit of RNase Tg; incubation was for 2.5 hours at 
37'C. Two-dimensional thin layer chromatography (Nishimura, 
1974) was used to analyze the nuclease digests. The RNase 
hydrolyzates, to which a mixture of unlabeled 5* or 3' 
nucleoside monophosphates (0.08 ^ 260 units each) was added as 
markers, were applied to a 20x20 cm cellulose thin layer plate 
(Merck, #5527). The first dimension was developed at room 
temperature with isobutyric acid : 0.5 M ammonium hydroxide 5 
: 3 (v/v), until the solvent front reached the top of the 
plate. After drying, the plates were developed in the scecond 
dimension with isopropanol : concentrated HCl ; water (70 : 15 
; 15 (v/v/v)). In an alternative procedure the solvents used 
in the first and second dimensions were, isobutyric acid : 
concentrated ammonium hydroxide ; water (66 : 1 ; 33 (v/v/v)) 
amd 0.1 M sodium phosphate, pH 6.8 : ammonium sulfate : n-
propanol (100 ; 60 ; 2 (v/w/v)), respectively (Silberklang et 
al., 1979). Marker compounds were visualized under a UV lamp 
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and P-labeled nucleotides were located by autoradiography. 
Radioactive spots were excised from the chromatogram and the 
amount of label determined by Cerenkov counting. 
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Val Sequence of in vitro transcribed tRNA 
The sequence of guanosine residues in synthetic tRNA^^^ 
was determined by limited RNase T1 digestion of 5'-end [^^P]-
labeled tRNA according to Donis-Keller et al. (1977). A 5 /il 
reaction mixture containing 5'-end [^^P]-labeled tRNA^^^ 
(about 40,000 cpm determined by Cerenov counting), 20 mM 
sodium citrate, pH 5.0, 1 mM EDTA, 0.56 mg/ml carrier tRNA, 
4.2 M urea, 0.025% xylene cyanol FF, 0.025% bromophenol blue, 
and 0.4 units RNase T1 was incubated at 50"C for 10 minutes. 
The reaction was stopped by immersion in ice and the sample 
was loaded onto a 15% polyacrylamide/8M urea gel (300 x 400 x 
0.4 mm); a native RNA ladder generated by incubating 5'-end 
[^^P]-labeled tRNA^^^ at pH 9.5 for 90 minutes was loaded in 
an adjacent well. Electrophoresis was carried out at 1800V 
until the bromophenol blue migrated to the bottom of the gel. 
RNA bands in the gel were detected by autoradiography. 
Purification of valvl-tRNA synthetase fVRS) 
E. coli GRB238/pHOVl used for the preparation of valyl-
tRNA synthetase was grown in the medium described by Skogman 
and Nilsson (1984): LB medium (Maniatis et al., 1983) 
supplemented with medium E (Vogel, 1956), 0.2% glucose, 1 
jug/ml thiamine and 30 /xg/ml ampicillin. An overnight growth 
was diluted 20 to 1 and grown at 40°C with constant shaking 
for 4 hours to the late log phase. Cells were then harvested 
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by centrifugation. The average yield of cells was 5g per 6 
liters of culture. 
All operations in the preparation of the synthetase were 
performed at 4°C and all centrifugations were carried out in a 
Beckman JA-20 rotor. 
Cell breakage Thirty-three grams (wet weight) of 
cells were suspended in 25 ml of 100 mM potassium phosphate 
buffer, pH 7.0, containing 0.5 mM EDTA, 1 mM DTT and 0.2 mM 
PMSF. The slurry was passed through a French pressure cell 
(Amicon) three times at 12,000 to 16,000 psi. Fifty ml of the 
same buffer was then added and the suspension was centrifuged 
at 15K rpm for 30 minutes. The supernatant was autolyzed by 
incubation at 37'C for 3 hours to destroy nucleic acids. Any 
precipitate formed was removed by centrifugation at 15K rpm 
for 30 minutes. , 
Ammonium sulfate fractionation Solid ammonium sulfate 
(277.3 g/1) was added to the supernatant to attain 45% 
saturation. After centrifugation for 15 minutes at 15K rpm, 
the supernatant was brought to 60% saturation by addition of 
97.5 g solid ammonium sulfate per liter. The precipitate was 
collected and redissolved in 40 ml of 100 mM potassium 
phosphate buffer, pH 7.0, containing 2 mM EDTA, 2 mM DTT and 
0.4 mM PMSF. An equal volume of neutralized 4 M ammonium 
sulfate was then added and any precipitate formed was removed 
by centrifugation. 
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Sepharose 4B chromatography A Sepharose 4B column 
(3.2 cm X 26.5 cm) was equilibrated with 50 mM potassium 
phosphate, pH 7.0, 1 mM EDTA, 1 mM DTT, 0.2 mM PMSF and 2 M 
ammonium sulfate. After applying the sample, the column was 
washed with 1 liter of the same buffer and VRS was eluted with 
a 2 liters reverse gradient of ammonium sulfate from 2 M to 0 
M in the same buffer. The enzyme was recovered from the 
column between 1.35 and 1.15 M ammonium sulfate. The peak of 
VRS activity was pooled, and protein was precipitated by bring 
the solution to 80% saturation with solid ammonium sulfate. 
This precipitate was collected and 
redissolved in 100 ml of 20 mM potassium phosphate, pH 7.0, 
0.5 mM EDTA, 1 mM DTT, ImM MgClg, 0.2 mM PMSF, 25% glycerol. 
Hvdroxvapatite•chromatography The partially purified 
enzyme from the Sepharose 4B step was subjected to 
chromatography on a hydroxyapatite column (3 cm X 11 cm) 
equilibrated with 20 mM potassium phosphate buffer, pH 7.0, 
containing 0.5 mM EDTA, 1 mM DTT, ImM MgClg, 0.2 mM PMSF and 
25% glycerol. After loading the sample, the column was washed 
with 500 ml of equilibration buffer containing 35 mM potassium 
phosphpate, pH 7.0, and protein was eluted with a linear 
gradient formed by mixing 500 ml of equilibration buffer 
containing 35 mM and 500 ml of the same buffer containing 150 
mM potassium phosphate. The peak of VRS activity was pooled 
and concentrated to 17 ml in an Amicon ultrafiltration cell 
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equipped with a PM 10 (Amicon Co.) Diaflo membrane. The 
concentrated protein was dialyzed against 3 changes, 4 liters 
each, of 10 mM potassium phosphate buffer, pH 7.0, containing 
15 mM MgClgf 1 mM DTT, 0.2 mM PMSF and 25% glycerol. 
Affi-Gel Blue chromatography After dialysis, the 
enzyme was applied to an Affi-Gel Blue column (2 cm X 5 cm) 
equilibrated with 10 mM potassium phosphate, pH 7.0, 15 mM 
MgClgf 1 mM DTT, 0.2 mM PMSF and 25% glycerol. The column was 
washed with 100 ml of 10 mM potassium phosphate, pH 7.0, 
containing 1 mM DTT, 0.2 mM PMSF, 50 mM NaCl and 25% glycerol. 
Elution of protein was carried out with a 1 liter linear 
gradient of NaCl from 0.05 M to 1.5 M prepared in the same 
buffer. 
The purified VRS, after chromatography on Affi-Gel Blue, 
was concentrated by pressure membrane filtration (PM 10) and 
was stored in 50% glycerol at -70'C at a concentration of 3 
mg/ml. Enzyme stored under these conditions was still fully 
active after 8 months. 
Protein determination 
Protein concentration was determined by the dye-binding 
assay of Bradford (1976), using bovine serum albumin as 
standard. Optical density was measured at 595 nm 20 minutes 
after adding the dye solution. 
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Amino acid analysis of VRS 
Purified VRS was dialyzed against HgO and hydrolyzed with 
6N HCl at 165°C for 1 hour. Amino acids were derivatized with 
PITC on an Applied Biosystem 42OA derivatizer and were 
separated by a reverse phase column on an Applied Biosystem 
13OA system. PTH-amino acids were detected at 254 nm. 
Amino-terminal sequence determination of VRS 
The amino-terminal sequence of the protein was determined 
by automatic Edman degradation. Purified VRS was dialyzed 
against HgO and lyophylized. The lyophilized protein was 
redissolved in 0.01% ammonium bicarbonate and analyzed with an 
Applied Biosystem 470A protein sequencer and 12OA PTH analyzer 
by Dr. L. Tabatabai at the National Animal Disease Center, 
Ames lA. 
Determination of free sulfhvdrvl groups 
Purified VRS was passed through an Affi-Gel Blue column 
to free it of sulfhydryl reagents and then dialyzed against 20 
mM potassium phosphate, pH 7.0. The number of free sulfhydryl 
groups in native VRS and in VRS denatured with 8M urea were 
determined as described by Ellman (1959) . 240 /xg of VRS were 
lyophylized and redissolved in 0.3 ml of 100 mM potassium 
phosphate, pH 8.0. DTNB, 0.1 mM, in 100 mM potassium 
phosphate, pH 7.0, 10 mM EDTA was then added to the sample. 
The formation of the dianion (TNB^-)(2-nitro-5-thiobenzoic 
acid) was measured by recording the absorbance at 412 nm. 
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Concentration of reacted sulfhydryl groups was calculated by 
equation 1 
where C^ is the concentration of reacted sulfhydryl groups, A 
is the absorbance at 412 nm, E equals 13600 M~^cm~^ and D is 
the dilution factor. 
Determination of ribonuclease activity 
To determine the extent of contamination of VRS 
preparations by RNase, tRNA^^^ (15 /xg, 0.58 nmole) was 
incubated with and without purified VRS (62.3 iJ.g, 0.58 nmole) 
in 50 mM Na-cacodylate, pH 7.0, 3 mM MgClg, 1 mM EDTA, 10 mM 
NaCl, 1 mM DTT for 20 hours at room temperature. Degradation 
of the tRNA was monitored by gel electrophoresis on a 15% 
polyacrylamide/8M urea gel. The abillity of the tRNA to be 
aminoacylated with valine was also tested. 
Gel filtration chromatography 
The molecular weight of native VRS was determined by gel 
filtration chromatography on a Zorbax GF-250 HPLC column (9.4 
X 250 mm). VRS and standard proteins were loaded on the 
column and eluted with 0.2 M ammonium phosphate, pH 7.0, at a 
flow rate of 0.5 ml/min. The molecular weight of VRS was 
determined by comparing the elution volume of VRS with that of 
the standards in a plot of elution volume against log M^. 
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SDS polvacrvlamide gel electrophoresis of proteins 
Electrophoresis of protein on 10% SDS-PAGE was performed 
as described by Laemmli (1970). Protein was stained with 1% 
Coomassie Brilliant Blue G-250 in 40% methanol and 10% acetic 
acid. 
Aminoacvlation reactions 
Activity of VRS was determined by aminoacylation assay in 
a 100 fil reaction mixture containing: 100 mM HEPES, pH 7.5, 
10 mM KCl, 10 mM ATP, 1 mM DTT, 20 mM MgClg, 5 nmole E. coll 
tRNA and 3.33 nmole ^^C-valine (90 mCi/mmole) or 0.5 nmole of 
^H-valine (2 mCi/pmole). Reactions were incubated for either 
10 minutes at 30"C (^^C-amino acid) or 6 minutes at 37°C (^H-
amino acid). Two ml of cold 5% trichloroacetic acid were 
added to stop the reaction. After 10 minutes on ice, the 
precipitates were collected on Millipore filters (0.45 ^ m), 
dried, and counted in a Beckman LS-IOOC scintillation counter 
in a toluene based scintillation cocktail containing 0.5% PPO 
and 0.01% POPOP. 
One unit of enzyme is defined as the amount of enzyme 
that will aminoacylate 1 jumole of ^^C-valine to tRNA in 10 
minutes at 30°C. 
Valine acceptance of tRNA was assayed (Gollnick, 1986) in 
a 100 /il mixture containing 100 mM HEPES pH 7.5, 10 mM KCl, 
100 mM ATP, 1 mM DTT, 20 mM MgClg, 22 fig S-100 enzyme and 3.33 
nmole of ^^C-valine (90 mCi/mmole). 
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Aminoacvlation kinetics 
Kinetic properties of purified VRS were determined as 
follows: transfer RNA was charged with ^^C-valine in a 50 jul 
reaction mixture consisting of 100 mM HEPES, pH 7.5, 10 mM 
KCl, 15 mM MgClg, 7 mM ATP, 1 mM DTT, 150 nK ^^C-valine (133 
mCi/mmole), 1 ng purified enzyme and varying amount of tRNA as 
indicated. The mixture was preincubated at 25°C for 5 minutes 
before adding enzyme. Reactions were stopped after 5 minutes 
by addition of 5% cold trichloroacetic acid.' The precipitate 
was collected and counted as described for the assay of VRS. 
Initial velocity was determined as the amount of ^^C-valyl 
tRNA^®^ formed per minute. 
The kinetics of tRNA aminoacylation were determined at 
37°C in a 65 fil reaction containing: 100 mM HEPES, 10 mM KCl, 
15 mM MgC12, 7 mM ATP, 1 mM DTT, 99 iM of 3H-valine (5.04 
Ci/mmole) , 8.2 ng (1.17 nM) purified VRS and 0.3 to 2.7 /xM 
tRNA^^^. Ten ^.l aliquots were removed from each reaction 
mixture at 30-second intervals and spotted onto Whatman 3 MM 
paper, presoaked in 10% TCA. These samples were washed with 
TCA and ethanol as described by Bruce and Uhlenbeck (1982) and 
counted as described previously. Initial velocities were 
obtained with 5 different concentrations of tRNA at a fixed 
synthetase concentration. Valine transfer RNA concentration 
was determined from the plateau level of valine acceptance for 
each tRNA preparation. Before use, transfer RNA samples were 
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renatured by incubation at 55°C for 20 minutes, followed by a 
slow cooling to room temperature. and were determined 
by a linear-least square fit of the double-reciprocal plot of 
the data, using Cleland's program written in FORTRAN (Cleland, 
1979) and translated into BASIC by Ronald Viola (personal 
communication to Dr. H. Fromm, Iowa State University). 
NMR spectroscopy 
For ^^F NMR spectroscopy, transfer RNA samples were 
prepared as described by Gollnick et al. (1987). 5-
Fluorouridine has a pKa of 7.57 (Wempen et al., 1961) and the 
pKa of 5-fluroruracil in poly(FU) is 8.1-8.3 (Szer and Shugar, 
1963; Massoulie et al., 1963). ^®F NMR spectra of the 5-
fluorouracil substituted tRNAs were, therefore, recorded at pH 
6.0 to minimize effects of the dissociation of the N(3)-H of 
incorporated FUra. In vitro transcribed (FUra)tRNA^^^, after 
Toyopearl DEAE-650S column purification, was precipitated with 
ethanol and the pellet redissolved in 111% NMR buffer: 55.55 
mM sodium cocadylate, pH 6.0, 16.66 mM MgClg, 111 mM NaCl and 
1.11 mM EDTA. After dialysis against two 250 ml changes of 
the same buffer, the sample volume was adjusted to 0.3 ml and 
10%(v/v) DgO was added to serve as an internal lock signal. 
Transfer RNA samples were renatured by heating at 55°C for 20 
minutes and then cooling slowly to room temperature. The 
sample was then transferred to a Wilmad 529A-10 spherical NMR 
microcell which was suspended in a 10 mm NMR tube and 
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surrounded by sample buffer containing 1 roM 5-fluorouracil as 
an external standard. 
NMR spectra were obtained at 282 MHz on a Bruker WM-
300 pulsed FTNMR spectrometer at room temperature unless 
otherwise indicated. Data were accumulated by using 8K data 
points, no relaxation delay and a 30° excitation pulse, except 
when making area measurements, in which case a 90° pulse and a 
5 second relaxation delay were employed to ensure complete 
relaxation (Hardin and Horowitz, 1987). Chemical shifts are 
reported as ppm from free 5-fluorouracil; downfield shifts are 
indicated as positive numbers. When necessary, magnesium was 
removed from the tRNA sample by incubating diluted tRNA (0.6 
mg/ml) in 10 mM EDTA, pH 7.0 at 60°C for 5 minutes, and 
allowing the sample to slowly cool to room temperature. 
Transfer RNA was ethanol precipitated and redissolved in 
sample buffer that had been treated with Chelex 100 (Hardin et 
al., 1986). 
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RESULTS 
In Vitro Synthesis and Characterization of E. coli tRNA^^^ 
Construction of recombinant plasmid and in vitro transcription 
of tRNA^^^ 
An E. coli tRNA^^^ gene linked directly to a T7 RNA 
polymerase promoter was prepared in this laboratory by Ms. L. 
Li by ligation of six synthetic oligodeoxynucleotides as shown 
in Figure 4 (see Methods). The 105 base pair synthetic DNA 
fragment has a BstNl site at the 3' end of the tRNA^®^ gene 
and is flanked by EcoRl and BamHl sites. This construct was 
inserted into the EcoRI and BamHI sites of pUC119 to produce 
the recombinant plasmid, pVAL119-21, whose sequence was 
confirmed by dideoxy DNA sequence analysis (Figure 5a). 
pUC119 is a pUC plasmid carrying the intergenic region of 
bacteriophage M13. This permits packaging of single-stranded 
plasmid into viral particles after infection by helper phage 
(e.g., M13K07) for DNA sequencing and oligonucleotide-directed 
mutagenesis experiments (Vieira and Messing, 1987). 
For synthesis of tRNA^^^ in vitro, a suitable template 
was prepared by linearizing the recombinant plasmid with the 
restriction endonuclease BstNl. BstNl cleaves at the 3' end 
of the synthetic gene, leaving a coding strand that terminates 
with 3*-GGT-5'. Runoff transcription of this template 
produces a RNA product having the desired 5'-CCA-3' end. 
Eco RI 
* 
AATTCCTGCAGTAATACGAC 
GGACGTCATTATGCTGAGTGATATp 
pTCACTATA&GGTGATTAGCTCAGCIGGGAGAGCACCTC 
CCCACTAATCGAGTCGACCCTCTCGTGGAGGGAATGTTp 
+ 
Anticodon , Bam Hl 
pCCTTACAAGGAGGGGGTCGGCGGTTCGATCCCGTCATCACCCACCAG : 
CCTCCCCCAGCCGCCAAGCTAGGGCAGTAGTGGGTGGTCCTAG 
Bst NI 
T4 DNA Ligase 
(Isolate 105 mer) 
Eco RI pUC 119/Eco RI + Bam H l \ y  Bam H l  
^ y T7 Promoter , Vàl , ; 1 
GAATTCCTGCAGTAATACGACTCACTATAGCGTG^^^^^22_< %ÎZL.^^^CACC(AGGATCC 
CTTAAGGACGTCATTATGCTGAGTGATATCCCAC^"""^"T^ /^*"*"'^3GTGGTCCTAGG 
pVAL119-21 Bst NI 
Figure 4 Construction of the cloned E. coli tRNA^^^ gene 
Figure 5 DNA sequence of wild type and mutant tRNA^^^ 
genes (a) pVAL119-21; (b) pVAL64C; 
(c) pVAL41G. Positions where mutation takes 
place are indicated by an asterisk. 
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Transcription in the presence of the four usual nucleoside 
triphosphates produces unmodified tRNA^^^ that can be 
aminoacylated. A typical transcription reaction yields 55-60 
pmole tRNA per fil (determined by aminoacylation with ^^C-
valine) which corresponds to 1.4-1.6 mg active tRNA^®^ per ml. 
Transcription in the presence of FUTP instead of UTP yields 
1.2 mg active 5-fluorouracil-substituted tRNA^^^ per ml 
reaction. Electrophoresis of the transcription products on a 
15% polyacrylamide/8M urea gel shows that the normal in vitro 
transcript migrates more slowly than native E. coli tRNA^^^, 
while the 5-fluorouracil-containing transcript has the same 
mobility (Figure 6). 
After phenol and chloroform treatment to remove enzyme 
(see Methods), the tRNA transcript was subjected to Toyopearl 
DEAE-650S HPLC purification (Sampson and Uhlenbeck, 1988). 
The results in Figure 7 show that the tRNA (detected by 
aminoacylation activity) is eluted as a single peak at 
approximately 0.45 M NaCl. The front peak contains NTPs, 
incomplete transcripts, etc. The DNA template elutes with a 
retention time of about 30.5 minute (results not shown) and is 
present in the trailing edge of the tRNA transcript. This 
column, therefore, allows the separation of the transcript 
from DNA template and incomplete reaction products. 5-
Fluorouracil-substituted transcription products gave similar 
results (date not shown). 
Figure 6 Gel electrophoresis of tRNA on 15% 
polyacrylamide/SM urea gel 
(A) (FUra)tRNA^^^ transcribed in vitro in the 
presence of FUTP; (B) native (FUra)-substituted 
tRNA^®^, (C) in vitro transcribed normal tRNA^^^; 
(D) native normal tRNAVal from E. coli B. The 
minor fast migrating RNA in the native (FUra)-
substituted tRNA is the result of degradation 
on storage. Transfer RNA bands were visualized 
by UV translumination of the ethidium bromide 
stained gel. 
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Figure 7 Chromatography of in vitro transcripts on a Toyopearl-DEAE 
column 
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Transfer RNA recovered from a Toyopearl DEAE-650S column 
can be further fractionated by chromatography on a Gen-Pak FAX 
HPLC column (Waters). This column has been shown to resolve 
mixtures of native tRNA (Stowers et al., 1988; Bode and 
Horowitz, Iowa State University, unpublished observation) and 
it resolves the transcript into several peaks (Figure 8), only 
one of which can be aminoacylated by valine. The specific 
activity of the active tRNA^^^ pool is about 1200 pmole/Aggg. 
The results indicate that the Gen-Pak FAX column can be used 
to fractionate the heterogeneous tRNA transcript for further 
characterization. However, tRNA recovered from a Gen-Pak Fax 
column that had been used extensively had a lower than 
expected specific activity and showed evidence of possible 
degradation. 
Partial characterization of the tRNA transcript 
The sequence of G residues in the RNA transcript is that 
expected from E. coli tRNA^^^ as determined by a gel 
electrophoretic analysis of a partial RNase T1 digest of [5'-
32p]-end labeled transcript. Figure 9 shows that the 
guanosine residues appear at the expected positions in the RNA 
sequence. 
To ensure that transcription by T7 RNA polymerase started 
at the appropriate 5'-nucleotide and terminated at the 3'-CCA 
end of the tRNA^^^ gene, polyacrylamide gel purified 
transcript was subjected to 5'- and 3'- end group analysis 
^ w\ 
Retention Time (min) 
Figure 8 Gen-Eak FAX chromatography of the in yjtrQ transcribed 
tRNA pool recovered from the Toyopearl-DEAE column 
Figure 9 Partial ribonuclease T1 digestion of tRNA^^^ 
transcribed in vitro Transcribed tRNA^^^ was 
5•-end-labeled with as described in Methods. 
Lane 1, alkali ladder of 5'-end-labeled tRNA^^^; 
lane 2, tRNA^®^ incubated in the absence 
of ribonuclease Tl; lane 3, partial ribonuclease 
T1 digest of tRNA^^^. These 2 sets of lanes are 
the same; the right panel was electrophoresis 
for a longer period. 
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(see Methods). As shown in Figure lOA, pG is the only 
radioactive nucleotide detected when a snake venom 
phosphodiesterase digest of the in vitro transcript, post-
labeled with at its 5'-end, was analyzed by 2D TLC. This 
indicates that the transcription product has, as expected, a 
5' teirminal guanosine exclusively. 
In vitro transcribed tRNA^®^ has a 5'-terminal 
triphosphate. This is shown in Figure 11A which depicts the 
two-dimensional TLC separation of the nucleotides produced on 
complete RNase T2 hydrolysis of [a-^^P]GTP-labeled tRNA^^^. 
The 5'-terminal nucleotide will be phosphorylated on both the 
3'- and 5'-hydroxyls while interior residues are present as 
the nucleoside-3'-monophosphates. Figure llA shows a 
radioactive spot corresponding to the expected pppGp; no pGp 
is detected. As described by Sampson and Uhlenbeck (1988), 
priming the transcription of tRNA with excess GMP results in 
product terminating in a 5'-monophosphate. This is shown by 
two-dimensional TLC analysis of the RNase T2 digest of [a-
^^P]GTP-labeled transcript synthesized in the presence of GMP 
(GMP/GTP=4/1) (Figure IIB). The yield of active tRNA^^^ 
synthesized in the presence of GMP is up to 20% higher than 
that formed in the absence of GMP. 
Analysis of the 3'-end of the transcript reveals some 
heterogeneity. RNase T2 digestion of transcript labeled at 
its 3'-end by the T4 RNA ligase catalyzed addition of [5'-
Figure 10 5'- and 3'-terminal nucleotides of in vitro tRNA^^^ 
(A) Autoradiogram of a two-dimensional TLC of snake 
venom phosphodiesterase digested 5'- P end-labeled 
transcript; (B) Autoradiogram of a two dimensional TLC 
of RNase T2 digested 3*-^^P end-labeled transcript. 
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Figure 11 Autoradiograms of two-dimensional TLCs of RNase T2 
digested [a-^^P]GTP labeled tRNA^^^ 
tRNA^^^ transcribed in vitro in the absence (A) and 
presence (B) of GMP. 
67 
M 
m 
a 
I 
ai-*-* 
# o 
ai-
68 
32p]pcp shows that all 4 nucleotides are labeled by nearest-
neighbor transfer from [5'-^^P]pCp (Figure lOB). Cerenkov 
scintillation counting of the radioactive spots shows that 75% 
of the transcripts possess the expected 3'-terminal adenosine 
while 20% terminate in C, 4% in G and 1% in U. Heterogeneity 
at the 3'-end of the transcript was also found in other in 
vitro transcription systems (Sampson and Uhlenbeck, 1988; 
Reyes and Abelson, 1987; Samuelsson et al., 1988). 
In order to obtain more detailed information about the 
heterogeneous 3'-end, 3'-^^P end-labeled transcript was 
subjected to electrophoresis on a 12% polyacrylamide/8M urea 
sequencing gel (300 x 400 x 0.4 mm). After autoradiography, 
two bands were observed (Figure 12A). Each band was excised 
and its 3'-terminus determined as described earlier. Figure 
12B shows that the faster migrating RNA (band a in Figure 12A) 
has primarily a 3'-terminal A (the minor 3'-terminal C 
component observed probably results from contamination by the 
slower migrating band). This implies that the faster 
migrating (smaller) transcript corresponds to the product 
having the correct 3'-end. All four nucleotides (46% A, 44% 
C, 8% G, and 2% U) are found at the 3' end of the slower 
migrating RNA (band B in Figure 12A) (Figure 12C), suggesting 
that the larger minor transcription products are due to the 
random incorporation of additional nucleotides at the 3' end 
of the transcript. Non-template directed addition of extra 
Figure 12 Heterogeneity of the in vitro tRNA^^^ transcript 
(A) Electrophoretic separation of the 3'-^^P end-
labeled transcript on a 12% denaturing 
polyacrylamide gel. (B) and (C) Autoradiograms of 
a two-dimensional TLC of RNase T2 digested 
end-labeled transcript: (B) band a (lower); (C) 
band b (upper). 
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nucleotide was also found in the in vitro synthesis of DNA by 
some DNA polymerases (Clark, 1988). 
Aminoacvlation studies of native and in vitro transcribed 
tRNAy^l 
The efficiency of valine acceptance of in vitro 
transcribed normal and FUra-substituted tRNA^^^ (Toyopearl 
DEAE-650S purified) were compared to those of the tRNA^^^ 
purified from E. coli (Table 1). 
Table 1 Kinetic parameters for aminoacylation^ of native 
and transcribed tRNAs 
tRNA^ 
Apparent 
Km (MM) 
V 
(^mole^min/mg) 
native N 1.6 5.2 3.3 
native FU 1.4 3.5 2.5 
transcribed N 1.6 4.9 3.1 
transcribed FU 1.2 3.8 3.2 
Kinetic reactions were carried out as described under 
"Methods". 
N: normal; FU: 5-fluorouracil-substituted. 
Kinetic reactions were carried out at a saturating 
concentration of ATP (7 mM) and at 2 times the K^ of valine 
(99 /xM) . Kinetic data obtained under these conditions are 
essentially the same as those determined using saturating 
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concentrations of both ATP and valine (compare Table 1 and 
Figure 29). The value of native (FUra)tRNA^^^ is 
slightly lower in this experiment than in that shown in Figure 
29, primarily due to a decrease in tRNA specific activity 
after long term storage. 
In vitro transcribed normal and FUra-substituted tRNA^®^ 
have Kjjj and values similar to those of their native 
counterparts. The resulting indicates that both 
normal and FUra-substituted valine tRNAs transcribed in vitro 
have normal valine acceptance activity. 
^^F NMR spectra of in vitro transcribed FUra-substituted 
tRNaVBl 
The ^®F NMR spectrum of in vitro transcribed FUra-
substituted tRNA^^^ (purified on a Toyopearl DEAE-650S column) 
was compared to that of (FUra)tRNA^^^ isolated from FUra-
treated E. coli (native (FUra)tRNA^^^) in magnesium-containing 
buffer (Figure 13). Chemical shifts of all peaks in the 
spectrum of the fluorinated in vitro transcript are comparable 
to those of the native tRNA except for a small downfield shift 
of two peaks between 3.5 and 5..0 ppm (peaks E and F) of the in 
vitro transcript; an upfield shift of peak J in the transcript 
is also seen (Figure 13). Peak A of the in vitro transcript 
is also shifted downfield, but the chemical shift of this 
signal has been shown to be very sensitive to solution 
conditions (Hardin et al., 1986, 1988). Corresponding peaks 
Figure 13 NMR spectra of (FUra)-substituted tRNA^^^ 
(A) Native tRNA^^^ isolated from FUra-treated 
E. coli B; (B) in vitro transcript having 5'-
triphosphate terminus; (C) in vitro transcript 
having 5'-monophosphate terminus. Areas under 
each peak are indicated under the spectrum. 
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are designated A through N as described by Hardin et al. 
(1986) for native (FUra)tRNA^^^. The relative area of each 
peak was obtained by intergration on the spectrometer and 
these are indicated in Figure 13. NMR spectra of 
(FUra)tRNA^^^ transcripts carrying a 5'-terminal monophosphate 
and those with a 5'-triphosphate terminus are the same 
(compare Figure 13B and C), indicating that a 5' triphosphate 
end group has no effect on the conformation of the tRNA. 
The temperature dependence of the chemical shifts in the 
^^F NMR spectrum of the in vitro transcript is shown in Figure 
14. As temperature increases, peak F and H shift 
progressively downfield, peak M shifts slightly downfield, 
whereas peak K shifts upfield. All 14 peaks are resolved at 
47°C (Figure 14D). Similar temperature-dependent spectral 
changes were observed with native (FUra)tRNA^^^ (Hardin et 
al., 1986). The results suggest that there is no significant 
structural difference between in vitro transcribed and native 
(FUra)tRNA^^^ at high magnesium ion concentration. 
Conformational changes of (FUra)tRNA^®^ as a result of 
removing magnesium have been monitored by ^^F NMR spectroscopy 
(Hardin et al., 1986). Magnesium is known to stabilize the 
three-dimentional structure of tRNA (Schimmel and Redfield, 
1980; Hyde and Reid, 1985). The ^^F NMR spectrum of in vitro 
transcribed (FUra)tRNA^^^ recorded at low magnesium ion 
concentration differs from that of native (FUra)tRNA^^^. ^^F 
Figure 14 Temperature dependence of the NMR spectra of 
in vitro transcribed FUra-substituted tRNA^^^ 
(A) 22'Cî (B) 30'C; (C) 40*C and (D) 47'C. 
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resonances between 1.5 to 2.5 ppm in the spectrum of the in 
vitro transcript lose intensity, and are much less well 
defined than those in this region of the spectrum of native 
tRNA^^^ (compare Figures 15A and B). The changes are 
n I 
reversible, addition of Mg restores the spectrum to that 
observed at 15 mM Mg^"*". 
Assignment of Resonances in the NMR Spectrum of 
(PUra)tRNA^®^ 
site-directed mutagenesis of tRNA^^^ 
Mutant tRNAs in which individual FUra residues were 
replaced with other bases were prepared and used to assign 
resonances in the ^®F NMR spectrum of (FUra)tRNA^^^ and to 
study more clearly the requirements for specific tRNA 
recognition by valyl-tRNA synthetase. Mutations were 
introduced into the tRNA^^^ gene by site-directed mutagnensis 
(see Methods). Mutagenic primers used for producing tRNA^^^ 
mutants are summarized in Table 2. The sequence of each 
mutant was confirmed by dideoxy DNA sequencing. 
Assignment of FU64 in the T-stem 
E. coli tRNA^®^ contains a GU base pair in the T-stem. 
As a test of the method of assigning ^^F resonances by 
replacement of individual 5-fluorouracil residues, the G50-
FU64 base pair was converted to a G-C base pair by replacing 
FU64 with a C. The DNA sequence of the mutant pVAL64C is 
Figure 15 NMR spectra of (FUra)-substituted tRNA^^^ 
at low magnesium concentration 
(A) (FUra)tRNA^^^ transcribed in vitro : 
(B) native (FUra)tRNA^^^ isolated from 5-
fluorouracil treated E. coli cell (Spectrum 
taken from Hardin et al., 1986). 
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Table 2 Mutagenic primers and mutants produced 
Mutagenic primer Mutants 
•5 -GGTTCGATCCCGCCATC-3' C64 
5 -CAAGGGGGGGGTCGGCGG-3• G41 
5 -TATAGGGTGGTTAGC-3' G6 
5 -GCACCTCCCCTACAAG-3' C33 
5 
* 
-GCACCTCCCTCACAAG-3' C34 
5 -CAAGGCGGGGGCCGGCGG-3' C47 
5 -GTTCGAGCCCGTCATC-3' G59 
5 
* 
-GTTCGACCCCGTCATC-3• C59 
5 *** 3 -CTTA(AGT)AAGGAGGGGG-3'^ A36,G36,T36 
5 *** a -GGGTGAT(ACG)AGCTCAGCTGGG-3'^ A8,C8,G8 
Indicates position of the mutant. 
mixed oligonucleotides with three different bases at 
the same position. All three mutants were obtained in the 
same mutagenesis reaction. 
shown in Figure 5b. Comparison of the NMR spectrum of 5-
fluorouracil-substituted tRNA^^^C64 with the spectrum of wild 
type (FUra)tRNA^^^ (Figure 16) shows that they are essentially 
identical except for the absence of peak B at 6.67 ppm in the 
spectrum of the mutant. This allows the direct assignment of 
the F resonance at 6.67 ppm (peak B) to FU64 in the T stem 
of (FUra)tRNA^^^, and corrects the previous tentative 
Figure 16 ^®F NMR spectra of in vitro transcribed FUra-
substituted tRNA^®^ (A) Wild type tRNA^^^; and 
(B) mutant C64. The 19F resonance that 
disappears in the spectrum of mutant C64 is 
indicated by an arrow. 
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assignment of peak B to FU54 (Hardin et al., 1988). A small 
downfield shift of the peak at 3.27 ppm (peak I) is also 
observed. Overall, as judged by the NMR spectrum, the 
structure of (FUra)tRNA^®^ is not disrupted by the change of 
FU to C at position 64. Assignment of peak B represents a 
successful test of the assignment of resonances by the 
replacement of individual FUra residues, and the same method 
was used to assign additional peaks in the ^®F NMR spectrum of 
(FUra)tRNA^®^. 
Assignment of FU29 in the anticodon stem 
FU29 was assigned by replacing the FU29-A41 base pair 
with a FU29-G41 wobble base pair. The sequence of pVAL41G is 
shown in Figure 5c. The ^®F NMR spectra of (FUra)tRNA^^^G41 
and wild type (FUra)tRNA^®^, obtained at room temperature, are 
compared in Figure 17A and B. A new downfield peak at 7.7 ppm 
is observed in the spectrum of the mutant, and one of the two 
resonances in peak J/K (2.9 ppm) disappears. It was shown 
earlier (Figure 14D) that peak K, which overlaps peak J at 2.9 
ppm in spectra obtained at room temperature, shifts upfield to 
2.7 ppm and appears as a shoulder on peak L at 47°C. This 
shoulder is missing in the spectrum of mutant 41G obtained at 
47°C (Figure 17D). These results allow assignment of peak K 
to FU29 in the anticodon stem of (FUra)tRNA^^^. Additional 
changes noted in the spectrum of mutant G41 are the upfield 
Figure 17 ^®F NMR spectra of in vitro transcribed FUra-
substituted tRNA^^^ Spectra of wild-type 
tRNA^®^ (A) and mutant G41 (B) recorded at 
room temperature. Spectra of wild-type 
tRNA^^^ (C), and mutant G41 (D) recorded at 
47"C. The ^^F resonance that disappears in 
the spectrum of mutant G41 is indicated by 
an arrow. 
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shift of peak M to overlap with peak N and small shifts of 
resonances in the central region of the spectrum. 
Assignment of FU67 in the acceptor stem 
The mutant tRNA^^^ gene, pVAL6G, was constructed for the 
synthesis of (FUra)tRNA^^^G6. Replacement of the A residue at 
position 6 with a G, results in a G6-FU67 wobble base pair in 
the amino acid stem. As a consequence of converting the FU-A 
base to a FU-G wobble pair, peak L shifts downfield from 2.4 
ppm to 7.5 ppm in the ^^F NMR spectrum of (FUra)tRNA^^^G6 
recorded at room temperature (Figure 18). Peak L is, 
therefore, assigned to FU67 in the amino acid acceptor stem. 
It is also noted that peak G shifts upfield in the spectrum of 
mutant G6 (Figure 18). 
Assignment of FU33 and FU34 in the anticodon loop 
Positions FU33 and FU34 of (FUra)tRNA^^^ had been 
assigned previously by trinucleotide (GUA) and tetranucleotide 
(GUAA) codon binding experiments (Gollnick et al., 1986). To 
confirm these assignments by a more direct approach, the ^^F 
NMR spectra of (FUra)tRNA^^^C33 having FU33 replaced by a C 
and (FUra)tRNA^^^C34 with FU34 replaced by a C, were compared 
to the spectrum of wild type (FUra) tRNA^^^. Figure 19A and B 
depict the spectra of wild type and C33 mutant (FUra)tRNA^^^ 
at room temperature. All peaks are the same in these two 
spectra except for the resonance at 4.7 ppm whose intensity 
decreases in the spectrum of mutant C33. Either peak E or F 
Figure 18 ^®F NMR spectra of in vitro transcribed FUra-
substituted tRNA^^^ Wild type tRNA^^^ and 
mutant G6 (B). The ^^F resonance that 
disappears in the spectrum of mutant G6 is 
. indicated by an arrow. 
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Figure 19 ^®F NMR spectra of in vitro transcribed FUra-
substituted tRNA^^^ Spectra of wild type 
tRNA^^^ (A) and mutant C33 (B) recorded at room 
temperature. Spectra of wild type tRNA^^^ (C) 
and mutant C33 (C) recorded at 47°C. The ^^F 
resonance that disappears in the spectrum of 
mutant C33 is indicated by an arrow. 
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corresponds to FU33. Peaks E and F can be resolved at 47°C, 
peak F shifts downfield to 4.9 ppm at this temperature (Figure 
14D). Figure 19C and D show clearly that peak F (4.9 ppm) 
disappears in the spectrum of (FUra)-tRNA^^^C33 recorded at 
47"C, thus allowing the assignment of peak F in the ^^F NMR 
spectrum of (FUra)tRNA^^^ to FU33. 
The same approach was applied to the assignment of 
position FU34. ^^F NMR spectra of wild type and mutant 
(FUra)tRNA^^^C34 are shown in Figure 20. There is no 
difference between the spectra except that the intensity of 
peak G/H in the spectrum of (FUra)tRNA^^^C34 recorded at room 
temperature is decreased (compare Figure 2OA and B). Peak H, 
shifts downfield in the spectrum of (FUra)tRNA^^^ obtained at 
47°C, and this peak is missing in the spectrum of mutant C34 
recorded at this temperature (Figure 20C and D). Peak H is, 
therefore, assigned to FU34. Assignment of peaks F and H to 
FU33 and FU34, respectively, are consistent with previous 
assignments (Gollnick et al., 1986). 
Assignment of FU47 in the variable loop 
Position 47 was converted from FUra to C in mutant 
pVAL47C. Figure 21 compares the ^^F NMR spectra of wild type 
and mutant C47 (FUra)tRNA^^^. In spectra recorded at room 
temperature the intensity of peak E/F decreases. There are 
also spectral changes in the upfield region between 2.5 and 
3.7 ppm (Figure 21A and B). At 47°C, peak E disappears in the 
Figure 20 ^®F NMR spectra of in vitro transcribed FUra-
substituted tRNA^^^ Spectra of wild type 
tRNA^®^ (A) and mutant C34 (B) recorded at room 
temperature. Spectra of wild type tRNA^^^ (C) 
and mutant C34 (D) recorded at 47°C. The ^®F 
resonance that disappears in the spectrum of 
mutant C34 is indicated by an arrow. 
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Figure 21 ^®F NMR spectra of in vitro transcribed FUra-
substituted tRNA^^^ Spectra of wild type. 
tRNA^^^ (A) and mutant C47 (B) recorded at room 
temperature. Spectra of wild type tRNA^^^ (C) 
and mutant C47 (D) recorded at 47°C. The ^^F 
resonance that disappears in the spectrum of 
mutant C47 is indicated by an arrow. 
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spectrum of mutant C47 (Figure 21C and D). These results lead 
to assignment of peak E, which resonates at the same chemical 
shift as peak F at room temperature but is resolved at 47°C, 
to FU47 of (FUra)tRNAVal. 
Assignment of FU59 in the T-loop 
Position FU59 was assigned by comparing the spectrum of 
mutant (FUra)tRNA^®^G59, which has FU59 replaced by G, to that 
of wild type (FUra)tRNA^^^ (Figure 22). Peak C in the 
spectrum of mutant G59 disappears (Figure 22), allowing 
assignment of peak C to FU59 in the T-loop. 
The ^^F NMR spectrum of mutant (FUra)tRNA^^^C59, in which 
FU59 is replaced by C, was also recorded (Figure 22C). The 
spectrum of this tRNA, in addition to missing peak C, shows 
peak I shifted upfield to 0.8 ppm. 
^^F NMR spectra of fFUra)tRNA^^^ mutated at position 8 
5-Fluorouracil at position 8 of (FUra)tRNA^^^ was 
replaced by G, C and A, to assign FU8 and to investigate the 
role of uracil 8 in the recognition of tRNA by aminoacyl-tRNA 
synthetase (Schoemaker and Schimmel, 1977). Figure 23 shows 
the ^^F NMR spectra of (FUra)tRNA^®^ mutants A8, C8 and G8. 
Broad, poorly resolved peaks are observed in all regions of 
the spectrum of each mutant. 
Spectra of (FUra)tRNA^^^ mutants A8, C8 and G8 obtained 
at low magnesium ion concentration show somewhat better 
defined spectra than those recorded in the presence of Mg^^ 
Figure 22 NMR spectra of ijn vitro transcribed FUra-
substituted tRNA^®^ (A) Wild type tRNA^^^; 
(B) mutant G59; (C) mutant C59. The ^®F 
resonance that disappears in the spectra of 
mutant G59 and C59 is indicated by an arrow and 
the resonance that shifts upfield in the 
spectrum of mutant C59 is indicated by an 
asterisk. 
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Figure 23 ^®F NMR spectra of in vitro transcribed FUra-
substituted tRNA^^^ (A) Wild type ; 
(B) mutant C8; (C) mutant A8; (D) mutant G8. 
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(Figure 24). The peak appearing at 3.3 ppm in the spectrum of 
wild type (FUra)tRNA^^^ is missing in the spectra of mutants 
A8, C8 and G8 (compare Figure 24A, B, C, and D). This 
resonance is identified as peak I by comparing the magnesium 
ion concentration dependence of the chemical shifts of 
resonances in the spectra of transcribed (FUra)tRNA^^^ (data 
not shown) to those of native (FUra)tRNA^®^ (Hardin et al., 
1986). Resonances in the upfield region (between 1.5 and 2.5 
ppm) of mutants A8 and C8 are not well defined, similar to the 
results obtained with wild-type in vitro transcribed 
(FUra)tRNA^^^. Native (FUra)tRNA^^^ has 5 well resolved peaks 
in this region of the spectrum (Figure 15B). Suprisingly, 
(FUra)tRNA^^^G8 at low magnesium concentration gives a ^^F NMR 
spectrum that differs from that of the other mutants and from 
wild-type tRNA in showing numerous well defined resonances in 
the upfield region (Figure 24D). 
Because of the poorly defined spectra of mutants at 
position 8, it is difficult to assign this Fura by the base-
substitution method. However, it is possible that the missing 
peak at 3.3 ppm (peak I) in the position 8 mutants is FU8. 
Figure 24 ^^F NMR spectra of in vitro transcribed FUra-
substituted tRNA^^^ recorded at low magnesium 
concentration (A) Wild type; (B) mutant C8; 
(C) mutant A8; (D) mutant G8; 
(E) superimposition of spectra (A), heavy line; 
and (B), thin line. 
MN 
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Recognition of (PUra)tRNA^®^ by Valyl-tRNA Synthetase 
Purification of valvl-tRNA synthetase from an overproducing 
strain of E. coli 
Valyl-tRNA synthetase was first purified by Yaniv and 
Gros (1969) from wild type E. coli cells. With the 
development of recombinant DNA techniques, E. coli strains 
harboring an overexpressed plamid earring the VRS gene were 
constructed (Skogmen and Nilsson, 1984). The amount of VRS in 
the crude cell extract of this particular strain was 
calculated to be 1.5-1.75% of the total cellular protein. 
With this advantage, purification of valyl-tRNA synthetase 
from E. coli was carried out by a different and simpler 
procedure than that published previously. A crude extract 
prepared from E. coli GRB 238 which has the recombinant 
plasmid pHOVl containing the VRS gene sequence, shows a 12 
fold increase of VRS specific activity compared to an extract 
from wild type E. coli B. The extend of overproduction is 
similar to that found by Dr. Marchin (Kansas State University, 
personal communication). The enzyme was successfully purified 
to homogeneity by three column chromatographic procedures. 
The crude E. coli extract, prepared by breaking cells in 
a French Pressure cell, was heated at 37°C to autolyze nucleic 
acids. After ammonium sulfate fractionation the enzyme was 
purified by chromatography on Sepharose 43, which effectively 
removes 85 percent of the proteins with high recovery of VRS 
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activity (Figure 25A). Further purification of VRS was 
achieved by hydroxyapatite chromatography (Figure 25B). This 
column removes proteins with molecular weights of about 10OK 
and 120K (compare Figure 26f and 26g), which are difficult to 
eliminate by other means. 
Affi-Gel Blue was used in the last purification step. VRS 
eluted as a single peak between 0.3 M and 0.5 M NaCl (Figure 
25C). After this step, the enzyme was judged to be more than 
98% pure by SDS-PAGE (Figure 26h). Six mg of VRS was obtained 
from 23 g of wet cells. The specific activity of the purified 
VRS was 31 to 35 units per mg protein. The overall 
purification of the VRS is summarized in Table 3 and an SDS-
polyacrylamide gel of each stage in the purification of VRS is 
shown in Figure 26. A later, larger scale purification of VRS 
yielded 150 mg of enzyme from 216 g of cells with a 50% 
recovery of total activity. 
The enzyme purified by this procedure was tested for the 
presence of contaminating' ribonuclease activity. E. coli 
tRNA^^^ was incubated with purified VRS overnight at room 
temperature (see Methods) and analyzed on a 15% 
polyacrylamide/8M urea gel (results not shown). Little 
degradation of tRNA^®^ was observed under these conditions. 
In fact VRS partially protected the tRNA^®^ from degradation. 
The valine acceptance activity of the tRNA^^^ was found to be 
Figure 25 Purification of valyl-tRNA synthetase 
(A) Sepharose 4B chromatography of valyl-tRNA 
synthetase. Fractions of 8 ml were collected 
at 0.8 ml/min. 
(B) Chromatography of valyl-tRNA synthetase on 
hydroxyapatite. Four ml fractions were 
collected at a flow rate of 0.1 ml/min. 
(C) Purification of valyl-tRNA synthetase on 
Affi-Gel Blue chromatography. Four ml per 
fraction was collected at a flow rate of 
0.4 ml/min. 
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Figure 26 SDS-PAGE at each stage of the purification of 
valyl-tRNA synthetase from E. coli GRB238/pHOVl 
a. Standard proteins; B-galactosidase (MW. 
116,000); phosphorylase b (MW. 97,200); bovin 
serum albumin (MW. 67,000); ovalbumin (MW. 
43,000) and carbonic anhydrase (MW. 29,000); 
b. crude extract (54 ng of protein); c. 
autolysate (58 ng); d. 45% ammonium sulfate, 
supernatant (50 jug) ; e. 60% ammonium sulfate, 
precipitate (50 fig); f. Sepharose 4B pool (19 
/ig) ; g. hydroxyapatite pool (16 fjLg) ; h. Affi-
Gel Blue pool (7 ng). 
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Table 3 Purification of valyl-tRNA synthetase from E. coli 
GRB238/PHOV1. 
23 g of cells was treated as described in "Methods". 
Fraction 
Total mg 
protein 
Total 
units 
Units/ 
mg protein 
Fold 
purification 
% 
yield 
crude extract 2230 1237 0.555 1 100 
autolysate 1902 1287 0.677 1.22 104 
45% (NH^lgSO^fSup 1008 985 0.977 1.76 80 
60% (NH^igSO^fPpt 715 859 1.201 2.16 69 
Sepharose 4B 105 702 6.686 12.05 57 
Hydroxyapatite 9.24 337 11.525 20.77 27 
Affigel-blue 6.25 198 31.680 57.08 16 
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1200 pmole/AggQ after overnight incubation at room temperature 
without enzyme and 1390 pmole/Aggg after incubation with VRS. 
Partial characterization of valvl-tRNA synthetase 
The molecular weight of purified VRS was determined by 
gel filtration under nondenaturing condition (Figure 27A) and 
by SDS-PAGE (Figure 27B). Both methods gave the same results, 
indicating that valyl-tRNA synthetase is a single polypeptide 
with a molecular weight of 108,000 daltons. The results are 
comparable to those inferred from the DNA sequence (Heck and 
Hatfield, 1988; Hartlein et al., 1987) and the VRS purified 
from wild type E. coli K12 (Yaniv and Gros, 1969). 
The amino acid composition of VRS was determined and 
compared to that derived from the DNA sequence (Table 4). 
There is good agreement except for methionine. The low 
methionine content is probably due to the oxidation of 
methionine to methionine sulfoxide during hydrolysis of the 
protein in the vapor phase. Methionine sulfoxide was not 
determined in this study. These results are, however, 
different from those previously reported by Yaniv and Gros 
(1969). 
The amino terminal sequence of VRS was determined by 
automatic Edman degradation performed by Dr. L. Tabatabai at 
the National Animal Disease Center, Ames lA. The results 
(Table 5) show that this sequence is met-glu-lys-thr-tyr-asn-
pro-gln-asp-ile. 
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Figure 27 Molecular weight determination of valyl-tRNA synthetase by 
SDS-PAGE and gel filtration 
(A) Migration of VRS to standard proteins on a 10% SDS-PAGE; 
(B) chromatography of native VRS and standard proteins on 
Zorbax GF-250 HPLC column. 
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Table 4 Amino acid composition of valyl-tRNA synthetase 
mole 
Amino acid Purified VRS DNA sequence^ 
Asp + Asn 11.8 11.7 
Glu + Gin 12.8 12.4 
Ser 3.8 3.8 
Gly 8.3 7.2 
His 1.6 1.7 
Arg 6.4 6.8 
Thr 5.9 5.5 
Ala 9.0 8.6 
Pro 4.6 4.7 
Tyr 4.1 3.2 
Val 6.5 6.3 
Met 1.7 3.4 
lie 6.7 6.9 
Leu 8.8 8.3 
Phe 3.6 3.8 
Lys 5.0 5.8 
^Calculation are based on mole percent of each amino acid 
excluding cysteine and tryptophan which were not determined in 
this analysis. 
^Heck and Hatfield (1988). 
The number of free sulfhydryl groups in native and 
denatured VRS were determined as described by Ellman (1959). 
Figure 28 indicates that there are 3 and 5 free sulfhydryl 
groups in native and denatured VRS, respectively. 
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Figure 28 Reaction of valyl-tRNA synthetase with DTNB 
Free sulfhydryl groups in native and denatured VRS 
was determined by reaction with DTNB as described 
under Methods. 
• # native VRS; A a denatured VRS (in the 
presence of 8M urea). 
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Table 5 Amino-terminal sequence analysis of valyl-tRNA 
synthetase 
Cycle no. Major amino acid % yield 
1 Met 82.0 
2 Glu 60.8 
3 Lys 78.2 
4 Thr 42.5 
5 Tyr 59.1 
6 Asn 49.5 
7 Pro 62.4 
8 Gin 52.5 
9 Asp 51.2 
10 lie 56.7 
Aminoacylation of tRNA by synthetases involves three 
substrates; tRNA, ATP and amino acid. The kinetic parameters 
for VRS were determined as a one substrate system by varying 
the concentration of tRNA^^^ at fixed concentrations of ATP 
and valine (Figure 29). The concentrations of valine and ATP 
used in this analysis were 3 to 5 times their (Yaniv and 
Gros, 1969). Preliminary experiments showed that the 
aminoacylation reaction was linear for at least 6 minutes. No 
substrate inhibition by either ATP or valine was detected 
under the assay conditions used. values at 25"C of the VRS 
for both normal tRNA^®^ and FUra-substituted tRNA^^^ were 
approximately the same (Figure 29): 1.7 x 10~® M for tRNA^^^ 
and 1.5 x 10~® M for FUra-substituted tRNA^^^. These values 
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Figure 29 Determination of the kinetic properties of 
valyl-tRNA synthetase 
V and K for tRNA^^"^ (• •) and FUra-
suDstitutea tRNA (o o) were determined 
from the linear-least sequare fit of the 
double reciprocal plot. 
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compare well with the value of 0.6 x 10~® M at 30°C reported 
by Yaniv and Gros (1969), whereas they are 10 times higher 
than those previously determined using a crude SlOO cell 
extract (Horowitz et al., 1974). The of 6.3-6.6 ^mole 
per mg protein per minute for both normal and FUra tRNA^^^ in 
the present case is about 2 times higher than that reported by 
Yaniv and Gros (1969). 
Aminoacvlation of mutant tRNA^^^ transcripts 
The kinetics of aminoacylation of tRNA^^^ mutants with 
purified VRS are compared to that of the wild type tRNA in 
Table 6. 
(FUra)tRNA^®^ mutants C64, G59, C47, G6, and C33 have 
^max/^m values of 0.56 to 1.3 relative to that of the wild 
type tRNA. These results show that there is little or no 
effect of these base substitutions on the recognition of 
tRNA^^^ by VRS. Mutations at positions 41 (FU41G) and 34 
(FU34C) result in values 3 to 5 times lower than that 
of wild type (FUra)tRNA^^^. Replacement of C36 with an A 
produces a much greater decrease in to a level only 
0.11% of wild type (FUra)tRNA^®^. 
The decrease in valine acceptance activity of mutant A36 
is not due to the changes of tRNA structure resulting from the 
base substitution as seen in a comparison of the ^®F NMR 
spectra of wild type (FUra)tRNA^^^ and mutant A36 (Figure 30). 
The spectrum of mutant A36 is almost identical to that of the 
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Table 6 Kinetic parameters for aminoacylation^ of in vitro 
transcribed tRNA mutants 
tRNAVal 
Apparent 
Km (^M) 
V 
(/Ltmole/^min/mg) Vmax/Km (relative) 
FU-WT® 1.2 3.8 3.2 ( 1 ) 
FU64C® 1.2 3.1 2.6 0.81 
FU59G^ 1.1 4.4 4.0 1.25 
FU47C® 1.0 4.2 4.2 1.31 
FU6G& 1.2 3.7 3.1 0.97 
FU41G^ 3.4 2.4 0.71 0.22 
FU33C® 0.5 0.9 1.8 0.56 
FU34C® 1.0 0.92 0.92 0.29 
FU36A° 66.8 0.24 0.0036 l.lXlO"^ 
N36A° 9.7 0.20 0.021 6.6xi0"^ 
N36U° 45.9 0.14 0.0031 l.OxlO"^ 
N36G° 46.2 0.22 0.0048 1.5x10"^ 
•FU8A^ 6.6 2.2 0.34 0.11 
FU8C^ 10.5 3.7 0.35 0.11 
FUBG^ 21.6 0.22 0.011 3.4X10"^ 
^Transfer RNA concentration used in the reactions: 
^0.3-2.7 MM; °2.0-10.8 MM; °2.5-22.6 /LtM; °1.5-13.3 jLtM. 
Figure 30 ^®F NMR spectra of im vitro transcribed FUra-
substituted tRNA^^^ (A) Wild type tRNA^^^; 
and (B) mutant A36. 
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wild type tRNA, except for slight shifts of peak E/F. Judging 
from the NMR spectrum, the structure of (FUra)tRNA^^^ 
mutant A36 is unperturbed. 
To further confirm the importance of cytosine at position 
36 of tRNA^^^ for recognition by VRS, normal tRNA^^^ having A, 
G, or C in place of C36 were synthesized. The valine 
acceptance efficiency of these mutants are 150-1000 times 
lower than wild type tRNA^^^ (Table 6), indicating that normal 
tRNA^^^ mutants A36, G36 and U36 are all poorly recognized by 
valyl-tRNA synthetase. These results show that cytosine at 
the 3' position of the anticodon (position 36) of tRNA^^^ is 
required for specific recognition by its cognate synthetase. 
Replacement of FU8 in (FUra)tRNA^^^ with A, C, or G 
results in mutant tRNAs which have poorly resolved ^^F NMR 
spectra (Figure 23). The relative 3.1x10"^, of 
mutant G8 shows that this mutant tRNA is almost inactive in 
valine acceptance. However, (FUra)tRNA^^^ mutants AS and CB, 
with relative values of 0.11, remain a relatively 
effective substrate for VRS. 
^^F NMR spectral changes induced bv valvl-tRNA svnthetase 
binding to fFUra)tRNA^^^ 
Conformational changes in tRNA^®^ as it interacts with 
its cognate synthetase was monitored by NMR spectroscopy. 
Conditions were chosen to increase the affinity of the 
synthetase for tRNA (Bonnet and Ebel, 1975). The ^®F NMR 
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spectrum of native (FUra)tRNA^^^ recorded at 282 MHz in sodium 
cacodylate buffer, pH 7.0, containing 15 mM MgClg, 10 mM NaCl, 
1 mM EDTA and 10% DgO, shows 10 resolved peaks for the 14 FUra 
residues (Figure 31A), and is only slightly different from the 
spectrum recorded under standard condition (compare Figures 
31A and ISA). Addition of VRS induces several progressive 
spectral changes. The intensity of peak G/H at 4 ppm 
decreases gradually with increasing VRS concentration (Figure 
31). Other significant changes of the spectrum as a result of 
VRS binding to the tRNA are the progressive increase of 
intensity at 5.2 ppm, and the downfield shift of one peak from 
the cluster around 3.3 ppm (peaks I/J/K) to 3.7 ppm. At high 
levels of protein, a splitting of the two farthest downfield 
peaks (peaks A and B) is noted (Figure 3IF). Addition of BSA 
to (FUra)tRNA^^^ has no effect on the ^^F NMR spectrum (Figure 
32), indicating that the spectral changes observed in the 
presence of VRS are not due to nonspecific effects of added 
protein. 
Figure 31 The effect of valyl-tRNA synthetase (VRS) on 
the NMR spectrum of FUra-sbustituted tRNA^^^ 
Spectra were recorded in the absence of VRS (A), 
and in the presence of VRS at a molar ratio to 
tRNA of 0.16 (B); 0.31 (C); 0.45 (D); 0.67 (E); 
1.00 (F). 
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Figure 32 ^^F NMR spectra of FUra-substituted tRNA^^^ 
(FUra)tRNA^^^ before (A) and after addition 
of BSA, at a molar ratio to tRNA of (B) 1.0 
and (C) 1.6. 
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DISCUSSION 
In Vitro Transcription and Properties of Transcribed tRNA^^^ 
Fluorinated tRNAs having 5-fluorouracil in place of 
uracil and uracil-derived minor bases are ideally suited for 
the investigation of structure-function relationships by 
NMR spectroscopy. The usual method for obtaining 5-
fluorouracil-substituted tRNA was to purify it from 5-
fluorouracil-treated E. coli cells. This method has the 
disadvantages of low yields of fluorinated tRNA and needing 
long periods of time, 2-3 months, to purify a single tRNA 
species in the large amounts required for NMR studies. In 
vitro transcription of tRNA, described by Sampson and 
Uhlenbeck (1988), has been successfully and widely used to 
obtain large quantities of different species of unmodified 
tRNA (Sampson and Uhlenbeck, 1988; Reyes and Abelson, 1987; 
Hou and Schimmel, 1988; Schulman and Pelka, 1988). This 
technique has been applied in this study to the synthesis of 
coli tRNA^^^. 
Valine transfer RNA, having no modified bases, is 
prepared by in vitro transcription of a synthetic tRNA^^^ gene 
by T7 RNA polymerase. An average of 1.5 mg active tRNA^^^ per 
milliliter transcription reaction is obtained and the 
transcription product can be readily separated from template 
DNA and unincorporated nucleotides by chromatography on a 
129 
Toyopearl-DEAE HPLC column. Characterization of the tRNA 
indicates that 25% consists of molecules with extra 
nucleotides at the 3'-end. This non-template directed 
incorporation of nucleotides is also found in other in vitro 
transcription systems (Sampson and Uhlenbeck, 1988; Reyes and 
Abelson, 1987) and seems to be characteristic of bacteriophage 
RNA polymerases (Krupp, 1988). Further purification of the 
heterogeneous products can be achieved by electrophoresis on 
polyacrylamide gels (Sampson and Uhlehbeck, 1988) or 
chromatography on a Gen-Pak FAX column (Figure 8). The 
transcribed tRNA^^^, after Gen-Pak FAX purification, has a 
aminoacylation activity of 1200-1300 pmole/Aggg. This result, 
however, can not be reproduced after prolong use of the 
column. 
Incorporation of FUTP in place of UTP yields 5-
fluorouracil-substituted tRNA^^^. The large amount 
synthesized and the ease of purification of the tRNA make the 
in vitro transcription procedure a better way to produce 
fluorinated tRNA for ^^F NMR study. The valine acceptance of 
transcribed normal and FUra-substituted tRNA^^^, determined by 
aminoacylation kinetics , are quite similar to each 
other and to the activity of the native tRNA species (Table 
1) • 
^^F NMR spectroscopy shows that at high magnesium 
concentration, in vitro transcribed (FUra)tRNA^^^ resembles 
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the native (FUra)tRNA species produced in vivo. There are no 
significant differences between the spectra, obtained at 15 mM 
Mg^*, of (FUra)tRNA^^^ transcribed in vitro and that 
synthesized in vivo (Figure 13). The small downfield chemical 
shifts of peaks E and F in the spectrum of the transcript may 
be due to the absence of modified base in the (FUra)tRNA^®^ 
synthesized in vitro. As Figure 2 shows, (FUra)tRNA^^^ from 
E. coli grown in 5-fluorouracil-containing medium has two 
modified bases: m®A at position 37, adjacent to the 
anticodon, and m^G, which carries a positive charge, at 
position 46. FU47, which has been assigned to peak E (Figure 
21) is adjacent to an unmodified G of in vitro transcribed 
(FUra)tRNA^^^ but adjacent to m^G.in native (FUra)tRNA^^^. 
The positive charge on m G46 may account for the differences 
in the chemical shifts of peak E in the spectra of the two 
tRNAs. Similarly, methylation of A37 may change the 
conformation of the anticodon loop sufficiently to alter the 
environment of the fluorine at position 33 and produce the 
shift of this resonance. 
At low Mg^"*" concentration in vitro transcribed 
(FUra)tRNA^^^ is less stable than the native tRNA, as shown by 
1-9 the F NMR spectrum. Resonances in the upfield region of the 
spectrum of the transcript are less well defined and the 
intensity of peaks in the central part of the spectrum, where 
the signals from fluorouracils in loops of the tRNA are known 
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to resonate, is increased (Figure 15). A low stability of in 
vitro transcribed tRNA was also reported for yeast tRNA^^® by 
Sampson and Uhlenbeck (1988), who found that the in vitro 
transcript had a lower than the native tRNA. Sampson and 
Uhlenbeck speculated that the lower stability may be due to 
the absence of modified base in the transcribed tRNA. In the 
case of (FUra)tRNA^^^, the native FUra-substituted tRNA, which 
has a Tjjj similar to native normal tRNA (Horowitz et al., 
1974), has only 2 modified bases (Figure 4). It thus seems 
unlikely that the absence of modified bases is the major 
reason for the instability of in vitro transcribed tRNA. The 
factors responsible for the instability of the in vitro 
transcript need further investigation. 
Comparison of the ^®F NMR spectrum of (FUra)tRNA^^^ 
having a 5'-monophosphate (transcribed in presence of GMP) 
with that of tRNA having a 5'-triphosphate (transcribed in the 
absence of GMP), indicates that the nature of the 5'-end group 
T_Q has no effect on the F NMR spectrum and therefore on the 
overall structure of tRNA^^^ (Figure 13). Sampson and 
Uhlenbeck (1988) showed that the number of phosphates on the 
5' end of the transcript does not affect the activity of the 
tRNA. 
A study of temperature dependent changes in the spectrum 
of in vitro transcribed (FUra)tRNA^^^ shows that peaks F and 
H, assigned to FU33 and FU34 in the anticodon loop (Figure 19 
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and 20), as well as peak M shift downfield, and peak K shifts 
upfield as the temperature is increased (Figure 14). At 47°C, 
all 14 peaks in the spectrum of (FUra)tRNA^^^ are resolved. 
It was shown previously that the conformation of the anticodon 
loop in the (FUra)tRNA^^^ molecule, is sensitive to changes in 
temperature (Gollnick et al., 1987). With the assignment of 
peak K to FU29 in the anticodon stem, it can be concluded that 
the conformation of the entire anticodon arm is temperature 
dependent. 
Assignment of Resonances in the NMR Spectrum of 
(FUra)tRNA^^^ by Base Substitution 
We have systematically assigned ^^F resonances in the NMR 
spectrum of (FUra)tRAN^®^ by selectively replacing individual 
FUra residues with another base. This was accomplished by 
introducing base changes in the cloned tRNA^^^ gene, using the 
technique of site-specific mutagenesis. . ^^F resonances are 
assigned by comparison of the spectra of wild type and mutant 
(FUra)tRNA^^^. The ^®F NMR spectrum also serves as a means of 
monitoring conformational changes in the tRNA molecule 
resulting from the base substitution. 
There are five FUra residues located in loop regions of 
the (FUra)tRNA^^^ molecule. Four of these bases, FU59 (Figure 
22), FU47 (Figure 21), FU33 (Figure 19) and FU34 (Figure 20), 
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have been assigned to peaks C, E, F and H, respectively. 
Assignment of peaks F and H are consistent with earlier 
trinucleotide and tetranucleotide binding studies (Gollnick et 
al., 1988). Together with the previous assignment of peak D 
to FU17 based on the difference between the two isoacceptor 
sequences of native (FUra)tRNA^^^ (Hardin et al., 1988), all 
five fluorine probes located in loop regions of the 
Val (FUra)tRNA molecule have been assigned. These assignments 
agree with the study of the pH dependence of the ^®F NMR 
spectrum which showed that peaks C, D, E, F, and H are 
accessible to titration between pH 4.5-9 and have pKa's close 
to that of free 5-fluorouridine (Hardin et al., 1986). 
The behavior of peak C is different from that of the 
others in the central region of the spectrum in several 
respects. Peaks D, E, F and H have chemical shifts between 
4.2 and 5.5 ppm, while peak C is shifted somewhat downfield 
from this region and, has a broader peak width. Furthermore, 
the FUra residue corresponding to peak C neither reacts with 
bisulfite nor does it show a solvent isotope shift on transfer 
from HgO to DgO (Hardin et al., 1986). These data imply that 
this position is not solvent exposed and may be occupied by a 
5-fluorouracil residue hydrogen-bonded to other parts of the 
tRNA molecule. 
Peak C has been assigned to FU59 in the T-loop of the 
(FUra)tRNA^^^ molecule (Figure 33). The anomalous properties 
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of FU59, when compared to other FUra residues in loop regions 
of tRNA, are consistent with other reports in the literature. 
Residue U59 in yeast tRNA^^® was shown to have little 
reactivity with a variety of chemical reagents specific for 
pyrimidines in single stranded regions of tRNA (reviewed by 
Goddard, 1977). X-ray crystallographic studies show that the 
T-loop is buried in the tertiary structure of the tRNA 
molecule (Vlassov et al., 1981; Romby et al., 1985). In the 
crystal structure of yeast tRNA^^®, U59 is hydrogen bonded to 
a water molecule within the hydration shell of a Mg^"*" at one 
of the major magnesium binding sites of the tRNA, in the D-
loop (Quigley et al., 1979) (Figure 1). 
Valine transfer RNA from Bacillus subtilis has the same 
T-arm sequence as that of E. coli tRNA^^^ except that U59 is 
replaced by a G59 (Sprinzl et al., 1985). Replacement of 
position FU59 in E. coli tRNA^^^ with a G has little effect on 
tRNA structure, allowing assignment of the missing peak (C) to 
FU59 (Figure 22). When U59 is replaced by a cytosine, in 
addition to the loss of peak C a major upfield shift of peak 
I, to 0.8 ppm, occurs (Figure 22). Other smaller changes in 
the central region of the spectrum are also observed. The 
unusual upfield shift of peak I suggests a significant 
environmental change of one of the FUra residue in the tRNA 
molecule as a result of the substitution of FU59 by C. This 
might be explained by hydrogen bonding between the hydrogen of 
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the water molecule in the inner hydration sphere of the bound 
magnesium ion with oxygen-4 of FU59 (Quigley et al., 1978). 
Oxygen-6 of guanosine may also serve as a hydrogen bond 
acceptor, while the amino group substituent on C4 of cytosine 
may not. Having cytosine in place of 5-fluorouracil at 
position 59 would then interfere with the association of 
magnesium to this region of the tRNÀ and result in a partial 
disruption of the tRNA tertiary structure. 
Mutations at positions 33 and 34 in the anticodon loop 
have no major influence on tRNA conformation, as judged by the 
NMR spectra (Figures 19 and 20). The spectra of both 
mutant tRNAs, recorded at room temperature and at 47"C, are 
the same as those of wild type (FUra)tRNA^®^ except for the 
missing peaks. The missing peak, F in the spectrum of mutant 
C33, and H in the spectrum of mutant C34, can, therefore, be 
assigned to the corresponding FUra residues. 
Assignment of peak E to FU47 was accomplished by 
replacing FU47, in the variable loop, by a C. ^^F NMR spectra 
of mutant C47 recorded at room temperature and at 47"C show 
that peak E is missing (Figure 21). In addition to missing 
peak E, the ^^F NMR spectrum of mutant C47 exhibits several 
changes in the upfield and central regions (Figure 21), 
implying that local conformational changes of the tRNA have 
occurred as a result of the replacement of FU47 by C. 
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The first FUra residue involved in hydrogen bonding in a 
stem region of (FUra)tRNA^^^ molecule to be assigned was FU64, 
which is engaged in a non-Watson-Crick G-U base pair. 
Changing the wobble G-U base pair in the T-stem of E. coli 
(FUra)tRNA^^^ to a G-C Watson-Crick base pair, as expected, 
has no influence on the overall conformation of tRNA (Figure 
16). Therefore, the resonance missing in the ^^F spectrum of 
mutant C64 (peak B) is readily assigned to the FUra at 
position 64. The resonance from this helical hydrogen-bonded 
FUra appears in the downfield region of the spectrum. This 
assignment differs from that expected on the basis of previous 
results, which predicted that FUra's involved in secondary 
hydorgen-bonding would resonate in the upfield region of the 
^^F NMR spectrum (Horowitz et al., 1983). The assignment of 
FU64 suggests that the signal from FUra residues involved in 
wobble base pairing with G resonate in the downfield region of 
the ^^F spectrum. 
This prediction is supported by experiments in which FU-A 
base pairs were converted to FU-G wobble base pairs in other 
regions of the tRNA molecule. Such a replacement in either 
the anticodon stem (FU29-A41) or the acceptor stem (A6-FU67) 
results in the 4-5 ppm downfield shift of a single peak from 
the 2.5-3.2 ppm region of the spectrum to the 7-8 ppm range 
(Figures 17 and 18). The downfield shift of peak K in the ^^F 
NMR spectrum of mutant G41, due to the formation of the F29-
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G41 wobble base pair, allows assignment of peak K to FU29. In 
the NMR spectrum of mutant G6, peak L shifts downfield, 
when A6-FU67 is replaced by G6-FU67. Peak L can, therefore, 
be assigned to FU67 in the acceptor stem. 
It is also noted that in the spectrum of mutant G6, peak 
G shifts upfield (Figure 18). The A6-FU67 base pair in 
(FUra)tRNA^®^ stacks directly on top of the FU7-A66 base pair 
(see Figures 1 and 2). Replacement of A6 with a G may 
influence not only the environment of FU67 but also that of 
the adjacent FUra by changing the base stacking between the 
G6-FU67 and FU7-A66 base pairs. If this argument is correct, 
peak G could be assigned to FU7. Conclusive assignment of 
peak G will require additional evidence. 
The formation of the non-Watson-Crick FU-G base pair has 
been studied in several DNA oligomers, in which thymine is 
replaced by 5-fluorouracil (Sowers et al., 1987; Metzler and 
Lu, 1989; Coll et al., 1989). There are three possible forms 
of 5-fluorouracil when base paired with guanine: wobble, 
ionized, and enol tautomeric forms. Coll et al. (1989) showed 
that in crystal forms of d(CGCGFG) at pH 7.0 and pH 9.0, 5-
fluorouracil forms only a wobble base pair with guanine. No 
evidence of either the enol or the ionized form of 5-
fluorouracil was found. Sowers et al. (1987, 1988) 
demonstrated a difference in the chemical shifts of a FU-G 
base pair relative to a FU-A base pair in an ^^F NMR study of 
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fluorouracil-substituted synthetic deoxyoligonucleotide 
duplexes. They attributed the difference in chemical shift to 
the differences in stacking geometry between Watson-Crick (FU-
A) base pair and a wobble (FU-G) base pair, which may also 
explain the downfield shift of the FU-G base pair (peak B) in 
the case of (FUra)tRNAVal. 
Attempts were made to assign FU8, which is involved in 
tertiary hydrogen bonding with A14. The ^^F NMR spectra of 
mutants AS, GB, and C8, recorded at 15 mM magnesium, are not 
well resolved (Figure 23). The poor resolution may be due to 
partial distruption of tRNA tertiary structure resulting in 
mutilple conformations or aggregration of tRNA molecules. 
Removal of magnesium ion from these tRNAs results in better 
resolved spectra (Figure 24). 
The spectra of mutants A8 and CB, recorded at low 
magnesium concentration, are similar to that of the wild type 
(FUra)tRNA^^^ transcript except for a missing peak at 3.3 ppm 
(see Figure 24). By following the chemical shift changes of 
Va 1 the spectrum of transcribed (FUra)tRNA with decreasing 
magnesium concentration and comparing these to the shifts 
observed with native (FUra)tRNA^^^ (Hardin et al., 1986), the 
peak at 3.3 ppm can tentively be identified as peak I. 
Because the resonances in the upfield region are not well 
defined, it is difficult to be certain of this identification. 
If further experiments corroborate it, peak I can be assigned 
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to FUS. The spectrum of mutant G8 at low magnesium 
concentration is somewhat different from those of A8 and C8. 
We cannot explain the unique behavior of mutant GB. However, 
it is interesting to note that the aminoacylation activity of 
mutant GB is much lower than that of mutants AB and C8 (Table 
6 )  .  
The assignment of resonances in the NMR spectrum of 
5-fluorouracil-substituted tRNA^^^ are summarized in Figure 33 
and Table 7; assignments made in previous studies are shown in 
parentheses. FUra residues in unstructured regions of the 
molecule appear in the center (4-5 ppm) of the spectrum. 
resonances shift upfield when FUra base-pairs with A, while 
pairing with G causes a downfield chemical shift of the ^^F 
resonance. Peak A in the spectrum was previously tentatively 
assigned to FU55 on the basis of the observation that chemical 
shift position of the farthest downfield peak (A) in three 
(FUra)tRNAs, (FUra)tRNA^^^, (FUra)tRNA^^®^, and 
(FUra)tRNA^M®^, is sensitive to ionic strength and magnesium 
concentration (Hardin et al., 19BB). This similarity in 
behavior suggests that peak A corresponds to a FUra at an 
invariant position in all tRNAs. Although definitive 
assignment of this peak must await further confirmation, it is 
interesting to point out that FU55 is hydrogen-bonded to G18 
in the tertiary structure of the tRNA. 
Figure 33 Summary of resonance assignments in the NMR 
spectrum of (FUra)tRNA^^^ 
Spectra were recorded at room temperature (A) 
and at 47'C (B). Resonances assigned in other 
studies are shown in parentheses. Assignments 
indicated in box are still uncertain. 
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Table 7 Summary of resonances assignment in the NMR 
spectrum of (FUra)tRNA 
Peak Assignment 
A (FU55)' 
B FU64 
C FUS 9 
D (FU17) 
E FU47 
F FU33 
G {FU7}D 
H FU34-
I {FU8^* 
J 
K FU29 
L FU67 
M c 
N (FU4)3 
^Assignment was made in other studies. 
Assignment is still uncertain. 
^This resonance has not been assigned. 
Recognition of tRNA^®^ by Valyl-tRNA Synthetase 
To investigate the recognition of tRNA^^^ by its cognate 
synthetase, valyl-tRNA synthetase (VRS) was purified from an 
overproducing strain of E. coli. The purification procedure 
developed for this study is different from the purification of 
the enzyme from wild type E. coli reported by Yaniv and Gros 
(1969). Properties of the VRS prepared from the overproducing 
strain of E. coli were determined and these differ somewhat 
from those reported earlier (Yaniv and Gros, 1969). Valyl-
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tRNA synthetase is a single polypeptide chain with a molecular 
weight of 108,000 daltons (Figure 27). The purified VRS shows 
greater than 98% purity, is free of ribonuclease activity, and 
is suitable for use in studies with ribonucleic acids. 
The amino acid composition of purified VRS determined in 
this study differs from that previously published (Yaniv and 
Gros, 1969). The composition determined here, however, 
compares well with that derived from the DNA sequence of the 
VRS gene (see Table 4). Furthermore, the amino terminal 
sequence of the purified enzyme agrees with the DNA sequence 
and provides the first experimental support for the site of 
protein synthesis initiation in the VRS gene sequence (Heck 
and Hatfield, 1988; Hartlein et al., 1987). Sulfhydryl group 
determination of our VRS preparation by titration with Ellman 
reagent (Ellman, 1959) shows that there are 3 free sulfhydryl 
groups in native VRS and 5 sulfhydryl groups in the denatured 
enzyme. These results differ slightly from the previously 
reported values of 2 sulfhydryl groups in native VRS and 5 in 
the denatured enzyme (Yaniv and Gros, 1969) . 
The valine accepting activity of (FUra)tRNA^^^ mutants 
was assayed to determine the specific recognition sites of E. 
coli tRNA^^^ by valyl-tRNA synthetase. Possible 
conformational changes resulting from base substitution were 
monitored by ^^F NMR spectrum. 
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Mutation at position 64, in which the G-TU wobble base 
pair in the T-stem of (FUra)tRNA^^^ is changed to a Watson-
Crick G-C base pair has no effect on the structure of the tRNA 
molecule. The wobble GU base pair is commonly found in tRNAs; 
there is usually no more than one per molecule (Sprinzl et 
al., 1987). The role of this unusual base pair in the 
recognition of at least one transfer RNA by its cognate 
aminoacyl tRNA synthetases has been examined. The GU wobble 
base pair at position 3-70 in the acceptor stem of E. coli 
tRNA^^^ was shown to be a major déterminant for the specific 
recognition of the tRNA by a1any1-tRNA. synthetase (Hou and 
Schimmel, 1988; McClain and Foss, 1988a). In our experiments 
with tRNA^^^ the catalytic efficiency of VRS for (FUra)tRNA^^^ 
mutant C64 is only slightly, 19%, reduced relative to that of 
wild type tRNA. There is apparently little influence of 
mutation at position 64 on the aminoacylation activity, 
indicating that a G-U base pair in the T-stem of E. coli 
tRNA^^^ is not a crucial determinant for recognition by valyl-
tRNA synthetase. 
Replacement of the A6-FU67 base pair with a G6-FU67 base 
pair (mutant G6), in the acceptor stem of (FUra)tRNA^^^, leads 
to the assignment of FU67. Some shifting of peaks is observed 
in the spectrum of mutant G6 (Figure 18), however, the overall 
structure of the tRNA molecule is relatively unperturbed. The 
Vmax/Kjn value of this mutant is 97% that of the wild type 
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(FUra)tRNA^^^, suggesting that the A6-F67 base pair is not 
significant for synthetase recognition. 
Comparison of the aminoacylation activity of two mutants, 
G59 and C47, to that of the wild type tRNA^^^ is shown in 
Table 6. Replacement of FU59 by a G, as discussed earlier, 
has no influence on the structure of the tRNA molecule as 
judged from the NMR spectrum. However, replacement of 
FU47 with a C induces local conformational changes of the tRNA 
molecule (see previous discussion) . The values of 
these mutants are the same as that of wild type tRNA, 
demonstrating that positions FU59 in the T-loop and FU47 in 
the variable loop of (FUra)tRNA^^^ are not important for VRS 
recognition. Even local conformational changes around the 
variable loop region do not influence the recognition of tRNA 
by synthetase. These results agree with the general model of 
interaction between tRNA and synthetase proposed by Rich and 
Schimmel (1977) (see Figure 3 in Introduction). The variable 
loop and T-loop are located on the outside of the L-shaped 
tRNA molecule, away from the proposed synthetase binding 
sites, which are located along the inside of the L include the 
acceptor stem, the D-stem, and the anticodon. 
It was suggested that U8, which is conserved in all tRNA 
sequences determined to date (Sprinzl et al., 1978), is 
involved in the interaction of tRNA with aminoacyl-tRNA 
synthetase. Synthetase-catalyzed exchange of hydrogen for 
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tritium at U8 (Schoemaker and Schimmel, 1977) and inactivation 
of synthetase by 5-bromouridine (Starzyk et al., 1982), 
suggested a covalent adduct between the uracil-8 ring and the 
active site of the synthetase. The requirement for a U at 
position 8 for the recognition of tRNA^^^ by VRS was examined 
in this study. Position FU8 in (FUra)tRNA^®^ was replaced by 
A, C, or G. NMR spectra of (FUra)tRNA^^^ mutants A8, C8, 
and G8, recorded under standard conditions, are not well 
defined, indicating disruption of tRNA structure. The 
catalytic efficiency of mutant G8 is relatively low, 0.11% 
that of the wild type (FUra)tRNA^^^. (FUra)tRNA^^^ mutants AS 
and C8, however, have relative values of 0.11 
indicating significant aminoacylation activity. These data 
show that U8 is not absolutely essential for synthetase 
recognition. 
An involvement of the anticodon in the recognition of 
tRNA^^^ by its cognate synthetase was implied by Normanly and 
coworkers (1986), who studied the incorporation of amino acids 
into proteins by amber suppressor tRNAs (anticodon CAU), and 
found that tRNA^^^ with a CAU anticodon inserts lysine into 
protein at the site of the amber mutation. As described 
earlier (see Introduction) Schulman and Pelka (1988) found 
that tRNA^®^ can accept valine if the anticodon of tRNA^®^ is 
replaced by that of tRNA^^^. The involvement of the anticodon 
arm in the recognition of tRNA^^^ by VRS was studied by 
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selective replacement of positions FU33, FU34, C36 in the 
anticodon loop, and A41 in the anticodon stem. Replacement of 
FU33 in the anticodon loop of (FUra)tRNA^^^ by a C has no 
influence on either the structure of the tRNA molecule 
(compare NMR spectra of wild type and mutant C33 
(FUra)tRNA^^^ in Figure 19) or the valine acceptance activity 
of tRNA^^^ (compare values of FU-WT and FU33C in Table 
6). The results demonstrate that position FU33 is not 
specific for VRS recognition. 
(FUra)tRNA^^^ mutants with substitution at position 34 
(mutant C34) and 36 (mutant A36) were also studied. The 
NMR spectra of both mutants tRNAs are almost identical to that 
of wild type (FUra)tRNA^^^ (Figures 20 and 30), indicating 
that base substitution at these two positions does not disrupt 
tRNA structure. (FUra)tRNA^^^-C34 has a value only 
29% that of the wild type tRNA. (FUra)tRNA^^^-A36 has a 66 
times higher and a 15 times lower than the correspinding 
values for wild type (FUra)tRNA^^^, resulting in a 1000 fold 
decrease in Both positions seem to play a role in 
VRS recognition. The relatively small effect on valine 
acceptance activity of a mutation at position 34 is expected 
since the nucleotide at the wobble position must be able to 
recognize four valine codons (GUN). Replacement of C3 6 by A 
doés not change the structure of tRNA, but its ability to 
accept valine is almost lost. 
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The aminoacylation activity of normal tRNA^^^ mutants 
having position C36 substituted by A, G, or U was also 
determined (Table 6). All substitutions at this position 
yield tRNAs with values 150-1000 times lower than that 
of wild type tRNA^^^. These results demonstrate that the 
cytosine at position 36 of E. coli tRNA^®^, located on the 3' 
side of the anticodon, is a major determinant of valyl-tRNA 
synthetase recognition. 
No major changes in the structure of tRNA were observed 
by substitution of the FU29-A41 base pair in the anticodon 
stem of (FUra)tRNA^^^ by a wobble FU-G base pair. However, 
mutant (FUra) tRNA^^^G41 has a relatively low 0*22, 
indicating that mutation at position 41 affects recognition by 
synthetase. McClain et al. (1988) reported that the presence 
of a G-U base pair in the acceptor stem of tRNA^^^ causes a 
distortion of the RNA helix. The decrease in valine 
acceptance activity of mutant G41 may be due to similar 
changes in conformation of the anticodon stem. This implies 
the involvement of the anticodon stem in the recognition 
tRNA^^^ by valyl-tRNA synthetase. 
Using the 14 ^^F probes as site-specific reporters, the 
Va 1 
conformational changes of (FUra)tRNA induced by cognate 
synthetase binding was monitored by ^^F NMR spectroscopy. 
Because of the large size of the VRS (M^=108K daltons), the 
^®F resonances in the spectra of (FUra)tRNA^^^ complexed with 
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synthetase are considerably broadened. Several changes in the 
Val 
spectrum of (FUra)tRNA are observed as the result of 
synthetase binding (Figure 30). These changes are specific 
since addition of BSA has no influence on the spectrum of 
(FUra)tRNA^^^ (Figure 31). Intensity at 5 ppm increases upon 
synthetase binding; this resonance has not yet been assigned. 
One peak, which is likely to be peak I, shifts downfield from 
the cluster of peaks I/J/K (Figure 30). Peak I has 
tentatively been assigned to FU8. These results agree with 
the interaction between VRS and position 8 of the tRNA 
molecule reported with other tRNA-synthetase complexes 
(Schoemaker and Schimmel, 1977). 
Intensity of peak G/H in the central region of the 
spectrum decreases with increasing VRS/tRNA ratios (Figure 
30). Peak H has been assigned to FU34 in the anticodon of 
(FUra)tRNA^^^; peak G has not yet been assigned. If peak H is 
the one shifted on VRS binding, this result suggests that VRS 
either directly interacts with the anticodon of tRNA^^^ or 
indirectly induces a conformational change in the anticodon by 
binding to another region of the tRNA molecule. This 
observation is consistent with results discussed earlier 
showing that the anticodon of E. coli tRNA^^^ is involved in 
recognition by its cognate synthetase. 
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